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Global trends show that interest in fish products and fish consumption are increasing, while 
marine fishery resources are decreasing. Fish processing industry produces a high amount of 
residual raw materials that have nutritious proteins and other valuable compounds. An 
optimization of residual raw materials’ utilization can help meet the growing demand for fish 
products and help reduce environmental problems. A promising valorization method is 
enzymatic protein hydrolysis. In this project, enzymatic protein hydrolysis was performed to 
produce protein hydrolysates from complex material of Atlantic cod heads. Three types of 
material from cod heads (muscle, skin and bone) were hydrolyzed by 23 different proteases. 
The produced hydrolysates were analyzed and evaluated based on yield, molecular weight 
(determined by SEC and SDS-PAGE), selectivity of proteases towards collagen and 
myofibrillar proteins (selectivity ratio), and bioactivity properties (anti-proliferative, 
antioxidant and anti-inflammatory). It was determined that the highest yield from muscle was 
produced by Tail 191, from skin by Tail 194, and from bone by Tail 190. Different proteases 
produced hydrolysates with different average MW. Notably, Tail 189 produced hydrolysates 
with the lowest average MW from all three types of raw material. The SDS-PAGE patterns of 
the hydrolysates from skin indicated that Tail 193 and Endocut 01 might have selectivity 
towards peptide bonds they cleave. The selectivity ratio identified that Endocut 01 had the 
highest selectivity towards myofibrillar proteins and Flavourzyme was the only enzyme 
selective to collagen. The results of bioactivity assays showed no antiproliferative or anti-
inflammatory activity of the hydrolysates, however, all hydrolysates demonstrated antioxidant 
activity. The hydrolysates made from muscle showed higher antioxidant activity than the 
hydrolysates prepared from skin and bone. Based on the results, conditions for a scale-up 
experiment (from 5 g of raw material to 250 g) were suggested, which included 
recommendation of several enzymes per material, adjustment of temperature to optimal for 
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Regular fish consumption is recommended by WHO and FAO for a healthy diet (WHO & FAO, 
2003). In the last years, consumers have expressed increasing interest in fish and fish products, 
influenced by a global trend of eating healthy food (Korczek et al., 2018). According to FAO 
(2018), global consumption of fish increases by a yearly average of 3.2% (calculated between 
1961 and 2016) and was at 151.2 million tonnes in 2016. However, marine resources are limited 
(Tahergorabi et al., 2011); and according to FAO (2018) monitoring, marine fishery resources 
continue to decline. FAO (2018) reported that the fraction of marine fish stock caught within 
biologically sustainable levels was reduced from 90% in 1974 to 66.9 % in 2015. 
The fish processing industry produces a large amount of residual raw material, accounting for 
50-70% of the original raw material weight (Liu et al., 2015). Residual raw material is defined 
as discarded body parts of commercial fish (heads, trimmings, frames, skin, bones, gills, fins, 
viscera, blood, and roes) and bycatch (Vidanarachchi et al., 2014). The research institute 
SINTEF defines marine residual raw material as “the non-primary products obtained from the 
use of a marine raw material” (Richardsen et al., 2019). The residual raw material can be further 
separated into several groups depending on origin and handling: residual raw material and by-
product. When residual raw materials are handled in accordance with the hygiene regulations, 
they are called residual raw materials, and can be used for human consumption or feed. When 
residual raw materials are handled in accordance with the by-product regulations, they are 
called by-products, and are not allowed to be used for human consumption (Richardsen et al., 
2019). According to the EU regulations, by-products are divided into three categories based on 
their potential risk to human and animal health: category I (very high risk material), category 
II (high risk),  and category III (low risk) (EU Parliament & Council of the EU, 2009). 
Residual raw materials contain proteins, lipids and other valuable compounds such as calcium, 
astaxanthin, etc. (Rustad & Hayes, 2012). A small amount of residual raw material is used for 
human consumption, while the rest is used for production of animal feed, fishmeal and silage 
(Rustad, 2006). For example, in Norway 3.57 million tonnes of seafood was produced in 2018, 
which created 954 000 tonnes of residual raw materials, and 82 % of this residual raw material 
was utilized (Richardsen et al., 2019). These residual raw materials were used to produce a 
variety of products in different market areas (Figure 1). However, as Figure 1 shows, human 
consumption constitutes only 13%, where 11% is direct consumption (e.g. cod tongues, heads, 
roe) and 2% indirect consumption, which includes cod liver oil, ingredients for functional food 
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and flavoring additives in foods (extracts). Pharmaceutical products and supplements are also 
produced from Norwegian-based residual raw materials, but in very small amounts (Richardsen 




Figure 1 – Utilization of the residual raw materials in Norway in 2018: according to (A) the market areas and (B) 
product groups  (Richardsen et al., 2019). 
Large quantities of residual raw materials and growing demand for fish products can be solved 
by development of new technologies to better utilize fish processing residual raw materials. A 
considerable amount of research and effort has been conducted to optimize use of residual raw 
material and develop technologies to recover usable ingredients (Vidanarachchi et al., 2014). 
Currently, in Norway several companies are researching and developing methods to produce 
marine protein hydrolysates for human nutrition (Richardsen et al., 2019). Such optimization 
can help avoid future environmental challenges, produce value-added products and create new 
business opportunities (Liu et al., 2015). Seafood residual raw materials are considered to have 

























1.1.1 Atlantic cod and residual raw material 
Atlantic cod (Gadus morhua) is distributed across the Northern Atlantic from Atlantic Canada 
to Northern Europe (Figure 2 A) (Johansen et al., 2009). It is a fish with great economical value; 
according to Statistics Norway (2020), 327 648 tonnes of Atlantic cod was landed in 2019. The 
production of cod fillets can render up to 60% of the fish as residual raw materials (Gildberg et 
al., 2002). Atlantic cod can grow up to 1.8 m long and 55.6 kg (Moen & Svensen, 2004), and 
the head constitutes about 20% of the fish weight. Cod head (Figure 2 B) is a complex material 
containing muscle (55%), bones (20%), gills (15%), skin (5%)  and eyes (4%) with average 




Figure 2 – Atlantic cod. (A) Distribution in the Northern Atlantic. Figure taken from (King, 2007). (B) Atlantic cod 
head. Photo taken by L. Sorokina. 
 
1.1.2 Proteins – versatile macromolecules 
Proteins belong to a complex and diverse group of macromolecules. Based on function, proteins 
can be classified into nine major categories, which are presented in Table 1. Proteins are 
“polymers of amino acids, with each amino acid residue joined to its neighbor by a peptide 
bond” (Nelson & Cox, 2013). Proteins are also called polypeptides, and the difference between 
protein and peptide is in the number of amino acids in the chain. Generally, peptides have 






Table 1 – Major categories of proteins. Table made based on (Hardin et al., 2016). 
Class of proteins Function 
Enzymes catalysts that greatly increase the rates of chemical 
reactions 
Structural proteins  provide physiological support and shape to cells and 
organelles 
Motility proteins have important roles in the contraction and movement 
of cells and intracellular structures 
Regulatory proteins control and coordination of cellular functions, ensuring 
that cellular activities are regulated 
Transport proteins involved in the movement of other substances into, out 
of, and within the cell 
Hormonal proteins mediate communication between cells in distant parts 
of an organism 
Receptor proteins enable cells to respond to chemical stimuli from their 
environment 
Defensive proteins provide protection against disease 
Storage proteins   serve as reservoirs of amino acids 
Amino acids are building blocks of proteins, and 20 common amino acids are involved in  
protein synthesis (Hardin et al., 2016). All 20 amino acids share common structural features: 
an amino group, a carboxyl group, a hydrogen atom and an R group (or side chain). As shown 
in Figure 3, all of the groups are connected to the central carbon atom – alpha carbon (Hardin 
et al., 2016). Amino acids have different chemical characteristics due to differences in side 
chains; side chains vary in size, structure, and electric charge. In addition to 20 common amino 
acids there are many uncommon ones, which are modified after protein synthesis (post-
translational modifications) or are present in living organisms but are not part of proteins 




Figure 3 – Schematic structure of an amino acid.  Figure taken from (Hardin et al., 2016) 
R group 
(different for 
each amino acid) 
Amino group 
(ionized at pH 7) 
Carboxyl group 




In proteins and peptides, amino acids are covalently joint by peptide bonds. In the cell, the 
peptide bond formation and hydrolysis are controlled enzymatically. Peptide bond is formed 
between a carboxylic acid and an amino group (Petsko & Ringe, 2009) with release of a water 
molecule, as shown in Figure 4. 
 
Figure 4 – Peptide bond formation and hydrolysis. Peptide bond is a bond formed between a carboxylic acid and 
an amino group by the loss of a water molecule.  R1 and R2 represent different side chains. Figure taken from  
(Petsko & Ringe, 2009) 
Protein structure is commonly characterized by four levels: primary structure, secondary, 
tertiary and quaternary (Figure 5). Primary structure is the sequence of amino acids in a protein, 
which determines how the protein folds into higher-level structures. Secondary structure is 
either alpha helices or beta stands; they are local region of structure formed by hydrogen 
bonding between NH and CO groups of the polypeptide backbone. Tertiary structure is the 
overall three-dimensional arrangement of all atoms in a protein, and it depends on interactions 
between various R-groups. Quaternary structure describes proteins, which consist of two or 
more polypeptide chains, and characterizes three-dimensional arrangements of these complexes 
(Hardin et al., 2016; Nelson & Cox, 2013). 
A number of chemical interactions stabilize polypeptides, such as covalent bonds, disulfide 
bonds, salt bridges, hydrogen bonds, long-range electrostatic interactions and van der Waals 
interactions (Petsko & Ringe, 2009). Noncovalent bonds and interactions are weaker than 
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covalent but are numerous and important in folding and maintaining secondary, tertiary and 




Figure 5 – Levels of protein structure. (a) Primary structure: The linear amino acid sequence of the polypeptide 
chain including post-translational modifications and disulfide bonds. (b) Secondary structure: Local structure of 
linear segments of the polypeptide backbone atoms without regard to the conformation of the side chains. (c) 
Tertiary structure: The three-dimensional arrangement of all atoms in a single polypeptide chain. (d) Quaternary 
structure: The arrangement of separate polypeptide chains (subunits) into the functional protein. Figure taken from 
(Petsko & Ringe, 2009).  
Proteins can be denatured  by increased temperature, extremes of pH, certain miscible organic 
solvents, certain solutes, or detergents. All these denaturing agents have different modes of 
action, which disrupt noncovalent interactions within a protein. Denaturation cause formation 
of protein aggregates due to association of exposed hydrophobic surfaces, and denaturation can 
lead to protein precipitation (Nelson & Cox, 2013). 
1.1.2.1 Collagen in fish skin and bone 
Fish skin and organic matrix of bones consist predominantly of collagen (Harnedy & Fitzgerald, 
2012). Collagen is a fibrous protein, which consists of three α-chains intertwined into a right-
handed triple superhelical structure (collagen molecule), and each α-chain forms a left-handed 
helix (Gomez-Guillen et al., 2011). Depending on collagen type and source, three α-chains can 
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be identical or different; for example, type I collagen has two identical α1-chains and one α2-
chain and the size of each chain is ~100 kDa (Liu et al., 2015). Collagen molecules assemble 
into fibrils and fibrils form collagen fiber (Figure 6 A) (Hardin et al., 2016).  
The amino acid sequence of collagen is characterized by Glycine-X-Y repeating units (Figure 
6 B), where X is predominantly proline (Pro) and Y is hydroxyproline (Hyp). Presence of 
Glycine (Gly) at every third residue is essential for the formation of the collagen helical 
structure; since Gly is the smallest amino acid (has only a hydrogen as its R-group), it can fit 
into the center of the superhelix without any steric hindrance (Liu et al., 2015). Gly, Pro and 
Hyp make up approximately half of the amino acid residues in each α-chain, therefore, the other 
half of amino acids contribute to formation of different collagen types (Cui et al., 2007).  To 
date, 29 types of collagen have been identified with type I being the major fibrillar collagen in 
most fish organs (Liu et al., 2015). Collagen types differ in amino acid composition, sequence, 





                         B                      C 
Figure 6 – Collagen structure. (A) Structure of the collagen fibers. Figure is taken from (Hardin et al., 2016). (B) An 
α-chain, which has triplet of amino acids with glycine at every third position, X and Y. X position usually has proline 
and Y has 4-hydroxyproline. (C) A triple helix formed by tightly packed α-chains. Glycine is positioned in the center 
of the helix. The diameter of a collagen of the triple helix is 1.5 nm. Figure is taken from (Alberts et al., 2015). 
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Composition of fish skin  
Fish skin consists of several layers, as shown in Figure 7 A: epidermis, dermis and hypodermis 
(Burton & Burton, 2018). Collagenous fibers are found in the lower layer of dermis, stratum 
compactum, (Figure 7 B) and scales (Hawkes, 1974). The majority of collagen in fish skin 
belongs to type I, but some amount of type III is also present (Babel, 1996). According to work 
of Gordon & Lorimer (1960), skin from Atlantic cod consists of 75% collagen, 10% other 










Figure 7 – Fish skin. (A) Layers of fish skin: e – epidermis; s – scale; d – dermis; ds – stratum spongiosum; dc – 
stratum compactum; h – hypodermis. (B) Collagen fibers in the stratum compactum of winter flounder skin. Figures 
taken from (Burton & Burton, 2018). 
Fish bone structure 
Bones constitute approximately 10-15% of total fish biomass (Toppe et al., 2007). Bones are 
composed of mineral crystals (70%), extracellular organic matrix (20%) and cells (10%) (Heo 
et al., 2018). Collagen type I (90%) is a major component of the organic matrix, whereas the 
inorganic portion is primarily composed of hydroxyapatite (HA) crystals (S. Kim & Jung, 
1996). Hydroxyapatite crystals are embedded into the organic matrix, where functional groups 
of collagen interact with HA (Stock, 2015). The nucleation and growth of HA crystals can occur 
within the channels and gaps of collagen molecules and on the surface of the collagen fibrils 
(Cui et al., 2007). Bone tissue is highly complex and ordered mineral-organic composite 
material. This composite material is organized into layers (lamellae) and, depending on the 
Collagen fiber oriented 
longitudinally 









bone type, the layers are arranged into higher order structures (Cui et al., 2007). The basic 
building blocks of the zebrafish skeletal bone are shown in Figure 8. 
 
Figure 8 – Hierarchical organization of the zebrafish skeleton bone. Level 1: HA crystals and collagen fibrils. Level 
2: Mineralized collagen fibrils – the basic building blocks. Level 3: The array of mineralized collagen fibrils. Level 4: 
Two common fibril array patterns: arrays of parallel fibrils or a plywood-like structure. Level 5: The lamellar structure 
in one vertebra. Level 6: A vertebra. Level 7: Skeleton bone. Figure taken from (Cui et al., 2007). 
 
1.1.2.2 Myofibrillar proteins in fish muscle 
Fish skeletal muscle has white and dark muscle; and white muscle is usually more abundant 
than dark muscle (Kristinsson & Rasco, 2000). The proportion depends on the nature of the fish 
species, e.g. tuna (strong swimming fish) has more dark muscle than cod (a slow-moving fish). 
Dark muscle is enriched with oxygen-carrying haem proteins and has higher amount of lipids 
(Hall, 2011).  
Fish muscle consists of fibers, which are formed by many myofibrils, and myofibrils are made 
of myofibrillar proteins. In the space between myofibrils sarcoplasmic proteins are found.  
Fibers are bound together by connective tissue (stroma proteins) (Tahergorabi et al., 2011). 
Myofibrillar proteins constitute 65-75% (w/w) of total proteins in fish muscle, while 
sarcoplasmic proteins account for 15-35% (w/w) and stroma proteins make up on average 3% 
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of thick filament), actin (main component of thin filament), and regulatory proteins such as 
tropomyosin, troponin and actinin (Figure 9). Sarcoplasmic proteins consist of myoglobin, 
hemoglobin, globins, albumins, and some enzymes. While stroma proteins consist of collagen 
and elastin (Tahergorabi et al., 2011). 
 
Figure 9 – Structure of myofibrillar proteins (muscle tissue). White muscle consists of separate units called 
myotomes. Figure taken from (Tahergorabi et al., 2011). 
1.1.2.3 Proteolytic enzymes 
Enzyme is a biological catalyst, which “accelerates the rate of a chemical reaction without itself 
becoming permanently altered in the process” (Petsko & Ringe, 2009). Most enzymes are 
proteins with the exception of a small group of catalytic RNA molecules (Nelson & Cox, 2013). 
Proteolytic enzymes or proteases “catalyze the cleavage of peptide bonds in protein-based 
substrates” (Walsh, 2014b), as shown in  Figure 10 A. Proteases belong to a large and diverse 
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group of enzymes (Ward, 2011).  Most proteases show some selectivity towards the peptide 
bond they hydrolyze (Walsh, 2014b). Specificity of enzymatic reaction is connected to active 
site structure and characteristics of substrate (e.g. structure, shape and electrical 
complementarities) (Parkin, 1993b). 
Proteolytic enzymes can be classified based on several criteria such as source of enzymes 
(microbial, plant, animal), catalytic action (endopeptidase or exopeptidase) and characteristics 
of the active site (Adler-Nissen, 1993). Characterization as exopeptidases or endopeptidases is 
based on the position of the peptide bond in a substrate (Figure 10 B), which is hydrolyzed by 
an enzyme. Exopeptidases cleave peptide bond positioned on either the N terminus 
(aminopeptidases) or the C terminus (carboxypeptidases) of the protein-substrate, whereas 
endopeptidases hydrolyze peptide bone found internally in a protein (Ismail et al., 2019). 
Endopeptidases are further divided into several classes based on which amino acid residues or 
co-factors are essential in a catalytic site. The major classes are: serine proteases (e.g. trypsin), 
cysteine proteases (e.g. papain, bromelain), aspartic proteases (e.g. pepsin), metalloproteases 





Figure 10 – Proteolytic enzymes. (A) Serine protease mechanism of action. Figure taken from (Clark & Pazdernik, 
2016). (B) Cleavage site specificity of proteases. Figure taken from (Hooper, 2002). 
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Reactions catalyzed by enzymes are influenced by environmental conditions. In food 
processing applications enzymatic reactions encounter a broad spectrum of conditions. 
Therefore, how specific enzymatic reactions are affected by its environment is essential 
knowledge in order to control and optimize the process. The most dominant factors are 
considered to be pH, temperature and water availability (Parkin, 1993a). 
Industrial proteases are used, for example, in food industries, e.g. brewing (malting), baking 
(texture improvement), meat (meat tenderization), seafood (deskinning, fish protein 
hydrolysate) (Ismail et al., 2019). Industrial enzymes are produced in large quantities and are 
purified to a limited degree because economical considerations (e.g. production costs) are often 
essential for commercial success (Walsh, 2014a). Therefore, often detailed composition of 
industrial proteases is not available. Characterization of several commercial proteases, often 
used for hydrolysis of food proteins, have shown that e.g. Alcalase 2.4 L has three proteases in 
its composition, Corolase 2TS has two, while Flavourzyme 1000L has ten proteases (Merz et 
al., 2016).  
1.1.3 Valorization of residual raw material by enzymatic hydrolysis 
Enzymatic protein hydrolysis (EPH) is a process where “enzymes cleave the peptide bond 
between two amino acids” (Vang et al., 2018) in protein based substrates; during this process 
the molecular weight of proteins and peptides is decreased, the number of ionizable groups is 
increased and hydrophobic groups are exposed (He et al., 2013). In recent years, EPH have 
gained significant attention as a versatile processing technology. It is currently the most 
common method to produce hydrolysates from fish residual raw materials (Halim et al., 2016). 
EPH is used to recover a lipid phase, a soluble peptide fraction, and a non-soluble sediment 
(Aspevik et al., 2017; Böcker et al., 2017; Wubshet et al., 2017, 2018). EPH has replaced 
chemical hydrolysis because chemical hydrolysis has some drawbacks. These drawbacks 
include difficulty to control the process and products’ properties; harsh processing conditions; 
reduced nutritional quality of the product due to destruction of some amino acids; presence of 
large amounts of salts (formed as a result of neutralization process); residual organic solvents 
and toxic chemicals in the final product (Kristinsson & Rasco, 2000). Whereas EPH is 
performed under mild processing conditions (temperature, pH and pressure) (He et al., 2013). 
Application of commercial proteases for hydrolysis offers possibilities to control the 
characteristics of the product by the choice of enzyme, reaction conditions and time of 
hydrolysis (Rustad & Hayes, 2012).  
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The extracted protein hydrolysate is often used as a feed ingredient, while there is an interest 
in retargeting this product for human consumption. Fish residual raw material is a complex 
material for hydrolysis and the challenge is to produce hydrolysates with reproducible 
properties (Rustad & Hayes, 2012). Current biotechnological processes make it challenging to 
utilize the full potential of complex raw materials, creating a demand for further development 
of biotechnological processes (Nofima, 2018).  
1.1.4 Bioactive peptides in fish hydrolysates 
Bioactive peptides are peptides which exhibit biological activity (Halim et al., 2016), and this 
activity affects physiological functions of the organism (Hayes & McKeon, 2014). Generally 
marine bioactive peptides can be classified into three broad groups: naturally active peptides 
(can be directly extracted); peptides that can be produced by hydrolysis of parent proteins with 
the use of enzymes; and peptides produced by fermentation (Sable et al., 2017). 
In the last decades considerable research has been conducted to find bioactive peptides in fish 
protein hydrolysates. Studies show that fish proteins are an interesting source of bioactive 
peptides. Peptides from fish protein hydrolysates demonstrate a number of bioactive properties 
such as antioxidative, antihypertensive properties, antithrombic activity, immunomodulatory 
effect, anticancer activity, antimicrobial, and body weight reduction effect (Alemán & 
Martínez-Alvarez, 2013; Meram Chalamaiah et al., 2018; Cicero et al., 2017; N. R. A. A. Halim 
et al., 2016; Harnedy & Fitzgerald, 2012; Ishak & Sarbon, 2018; S. K. Kim & Wijesekara, 
2010; Korczek et al., 2018; Lordan et al., 2011; Ngo et al., 2012; Rocha et al., 2018; Sila & 
Bougatef, 2016). However, only a few studies investigated bioactive peptides in protein 
hydrolysate from Atlantic cod. The reported bioactivates are antioxidant activity (Farvin et al., 
2014, 2016; Girgih et al., 2015; Godinho et al., 2016; Jamnik et al., 2017; I. Jensen & Mæhre, 
2016; Pampanin et al., 2016; Slizyte et al., 2009), antiproliferative activity on cancer cell lines 
(Picot et al., 2006), ACE inhibitory activity (Dragnes et al., 2009; Godinho et al., 2016; Jeon et 
al., 1999), immunomodulatory effect (Y. Chen et al., 2019), and regulation of food intake 
(Cancre et al., 1999; Dale et al., 2018; Fouchereau-Peron et al., 1999; Slizyte et al., 2009). 
1.1.5 From laboratory to industry: challenges of upscaling   
Practical scale-up of biochemical and chemical processes is complicated and a case specific 
procedure (Piccinno et al., 2016). Therefore, understanding the nature of the process and the 
reasoning behind the process is essential (Shinnar, 2004). Characterization of enzymatic 
hydrolysis of residual raw material is a difficult task because it is “a combination of parallel 
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and consecutive occurring reactions” (Himonides et al., 2011). The main complicating factors 
are natural presence of enzymes inhibitors in the raw material and different susceptibility of 
diverse bonds in the proteins to different enzymes (Himonides et al., 2011). The final aim of 
the scale-up process is to deliver a product which fulfills quality specifications at the required 
production rate and yield on an industrial level (Shinnar, 2004). It is considered challenging to 
produce hydrolysates with the same quality specifications from residual raw materials on an 
industrial scale due to biomass complexity (different components in the mixture) and its 
variation in quality (oxidation state of protein components and oil, presence of microorganisms 
in the material, and activity of spoilage enzymes) (Vang et al., 2018).  
Enzymatic hydrolysis at a larger scale (> 2000 L) or industrial scale does not proceed the same 
way as it does at a laboratory scale (Vang et al., 2018). Scaling up is challenging because larger 
volume causes change in mixing, mass and heat transfer, and shear rate (Acosta-Pavas & Ruiz-
Colorado, 2020; Ehly et al., 2007; Shinnar, 2004). The most commonly used approach to 
control a scale-up process is to identify key factors and their impact on the process (Shinnar, 
2004).  Identification of these factors is easier if the scale-up process is divided into several 
steps by increasing volume, e.g. by 10-fold each step. Another option is to closely monitor the 
process of hydrolysis, which will allow to control and adjust processing settings (Vang et al., 
2018).  
Infrastructure is another factor influencing the scale-up process; industrial scale technologies 
are often different from laboratory equipment (Piccinno et al., 2016). The equipment that was 
used in the laboratory cannot always be applicable for a larger scale or can be 
difficult/expensive to get for industrial use (Vang et al., 2018). For example, lab scale 
centrifuges, which are used for separation of different phases after hydrolysis in the laboratory, 
are changed to a decanter or tricanter centrifuge on an industrial scale; or freeze-drying of the 
hydrolysate often used in the laboratory is changed to spray-drying on an industrial scale. It is 
also worth mentioning that economic factors should be taken into consideration from the early 





1.1.6 Research project Notably 
As mentioned earlier, in Norway several companies are involved in research and development 
of new methods to produce protein hydrolytes for human consumption (Richardsen et al., 
2019). One of these is the research institute Nofima, which coordinates the research project 
Notably (Novel cascade technology for optimal utilization of animal and marine by-products). 
The aim of Notably is to develop new technological solutions where processing of cod and 
chicken residual raw materials takes place in several different stages, so that multiple high-
value components can be extracted from the same rest raw material. Better biotechnological 
solutions have to be developed to achieve this goal; and enzymes play a central role in the 
solution. The traditional EPH leaves several valuable components such as minerals and non-
soluble collagen in sediment, and therefore the idea is to use more specific enzymes, which can 
release connective tissue proteins and myofibrillar proteins in separate stages. Better 
understanding of the enzyme’s action on different types of residual raw materials will enable 
future development of a multistep process. This multistep process, or cascade, will constitute a 
combination of several different processing steps, each one aimed at giving separate products 
with the highest possible yield and quality. The intention is that the cascade bioprocessing will 
result in better utilization of residual raw materials and increased value for food industry 
(Nofima, 2018).  
1.2 Methodological framework 
1.2.1 Enzymatic hydrolysis 
The method for enzymatic hydrolysis of fish meat was developed more than 70 years ago by 
Canadian researches (Gildberg, 1993) and today enzymatic hydrolysis “is one of the well-
recognized technologies in valorization of residual raw materials” (Wubshet et al., 2018). The 
main steps of enzymatic hydrolysis of fish material are shown in Figure 11. The process can be 
divided into three steps: pre-treatment, hydrolyzation and recovery.  
1) Pre-treatment step focuses on preparation of the substrate. Raw material is prepared for 
hydrolysis by making a homogenized water-mince mixture. The material is washed, ground or 
cut into small pieces, and then the minced material is mixed with water usually in 1:1 ratio (He 
et al., 2013).  
2) The next step is hydrolyzation – the selected enzyme is added into the homogenous mixture 
with the material. Selection of enzyme is based on the characteristics of the substrate and 
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desired functionalities of the final product. The temperature and pH are adjusted depending on 
the optimal conditions of an enzyme (He et al., 2013). However, pH adjustment is not 
recommended because use of acid or base, as mentioned earlier, can lead to reduction of 
nutritional value due to destruction of some amino acids and high levels of salt in the product 
(Aspevik et al., 2017). The enzyme/substrate ratio and processing time are determined 
according to the desired functionalities and yield of the final product. The hydrolysis process is 
terminated by heat inactivation of enzyme (90-95 °C for 10-30 min) (He et al., 2013). 
3) Recovery is the final step of the process. After the end of hydrolysis, the crude hydrolysate 
is separated into water phase, sediment phase and oil phase by centrifugation or three-phase 
decanter. The water phase, which contains dissolved protein hydrolysate, is freeze-dried or 
spray-dried, and can also be up-concentrated by evaporator before drying (Aspevik et al., 2017). 
 
Figure 11 – General workflow of enzymatic processing method to produce fish protein hydrolysate. Figure adapted 
from He et al. (2013). 
Fish processing co-products 
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1.2.2 Principles of size exclusion chromatography 
Size exclusion chromatography (SEC) is a “liquid column chromatographic technique that sorts 
molecules according to their size in solution” (Striegel et al., 2009). Currently SEC is the most 
popular method to determine molar mass distributions (Podzimek, 2010).  
Molecular weight (MW) determination by SEC starts with dissolution of a sample in a solvent 
(mobile phase) followed by injection of the solution into a column. The column is packed with 
porous particles and filled with a mobile phase. The mobile phase is going through the column 
at a fixed flow rate and thus creating a pressure gradient along the column. As a result of the 
pressure gradient, the sample molecules pass through the column. Figure 12 demonstrates how 
separation occurs based on a mixture of two groups of macromolecules with different sizes. 
The smaller molecules are able to get into the pores and are retained longer in the column, while 
bigger molecules are not able to fit into the pores and are going straight through the column. At 
the column outlet a detector generates a signal proportional to the concentration of eluting 
molecules (Malawer & Senak, 2004; Podzimek, 2010). SEC is “a relative and not an absolute 
molecular weight technique” and, therefore, calibration of columns should be performed with 
standards of known molecular weight (Mori & Barth, 1999). Since MW of peptides are 
important for their functionalities, SEC is widely used to determine the MW distribution of 
peptides in hydrolysates. 
 
Figure 12 – Separation of two macromolecular sizes by SEC: (1) sample mixture immediately after injection, before 
entering the column packing; (2) sample mixture enters the head of the column packing; (3) start of separation by 





1.2.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is another analytical 
method for separating proteins by size. It is the most common electrophoretic method applied 
to proteins (Walsh, 2014c). Electrophoresis is an “analytical technique that separates analytes 
from each other on the basis of charge” (Walsh, 2014c). SDS is a negatively charged detergent 
that binds to proteins at a ratio of ~1.4 g SDS per gram of protein, unfolds proteins and 
contributes to the overall negative charge of the protein-SDS complex (Bio-Rad Laboratories, 
2017). The polyacrylamide gel functions as a molecular sieve; it regulates the migration of 
proteins in proportion to their charge-to-mass ratio (Nelson & Cox, 2013). Gels have different 
concentrations of acrylamide; and gels with higher acrylamide concentration have smaller pore 
size (Invitrogen, 2016). When an electric field is applied, negatively charged protein-SDS 
complexes will migrate to anode based on their size (Figure 13). Molecular weight markers, 
containing a mixture of several known proteins of known molecular weight, are used to assess 
the relative sizes of the proteins in a sample (Invitrogen, 2016). After electrophoresis, protein 
bands are often visualized for analysis; and visualization is done by protein stains. Examples of  
protein stains include Coomassie stains, fluorescent stains and silver stains (Bio-Rad 
Laboratories, 2017; Invitrogen, 2016). 
 




1.2.4 Principles of in vitro bioactivity assays 
The following bioactivity assays are presented below: Aqueous One Solution Cell Proliferation 
assay (viability assay), oxygen radical absorbance capacity assay (antioxidant assay) and anti-
inflammatory assay. 
1.2.4.1 Aqueous One Solution Cell Proliferation assay 
Cancer is one of the major causes of death worldwide with an estimated 9.6 million deaths only 
in 2018 (WHO, 2018). Cancer is “an abnormal growth and proliferation of cells in the body” 
(Meram Chalamaiah et al., 2018). Cell division is a physiological process, which is tightly 
regulated under normal conditions. However, certain mutations can disrupt the regulation 
process and normal cells can be transformed into cancer cells; cancer cells start to divide 
uncontrollably and spread to surrounding tissues (Suarez-Jimenez et al., 2012). Thus, an 
important strategy for treating tumors is inhibition of deregulation of cell proliferation (Meram 
Chalamaiah et al., 2018). Cancer is a group of diseases, which can originate in almost any organ 
or tissue; and more than a hundred different types of cancer are characterized based on the site 
of origin and the specific cell type involved (Hardin et al., 2016). 
Cell-based assays are used to evaluate cell proliferation activity of a test compound. One of the  
common methods is tetrazolium reduction, where tetrazolium compound (e.g., MTS) is used to 
detect viable cells (Riss et al., 2016). Aqueous One Solution Cell Proliferation assay is a 
“colorimetric method for determining the number of viable cells in proliferation or cytotoxicity 
assays” (Promega, 2012). The principle of the assay is based on bio-reduction of tetrazolium 
compound (MTS) by metabolically active cells into a colored formazan product. The formazan 
product is soluble across cell membranes and is present in culture medium. The number of 
living cells in culture is directly proportional to the amount of formazan product that was 
formed. Color intensity (formazan product) is measured by recording absorbance at 490 nm 
and compared to cells in negative control wells (Promega, 2012).  
Various cancer cell lines (e.g., human liver cancer, human monocytic leukoma, human cervical 
cancer, human breast cancer) are used to investigate antiproliferative properties of test 
molecules. Different cell lines have their own morphology and tumor characteristics due to 




1.2.4.2 Oxygen radical absorbance capacity assay  
An inevitable part of aerobic metabolism is the formation of free radicals, which are highly 
reactive due to unstable unpaired electrons (He et al., 2013). Therefore, the human defense 
mechanism includes several antioxidant systems to prevent free radicals from causing damage 
(I. Jensen & Mæhre, 2016). However, under certain conditions the defense system cannot 
remove all free radicals. Free radicals cause cellular damage by oxidizing lipids, DNA and 
proteins (Alemán & Martínez-Alvarez, 2013), which can initiate diseases such as cancer, 
diabetes mellitus, atherosclerosis, arthritis (He et al., 2013), neurodegenerative disorders, 
inflammation (Girgih et al., 2015), cardiovascular disease, and aging (Cheung et al., 2015). 
Furthermore, oxidation of lipids during food processing and storage cause quality deterioration 
of food (Ahn et al., 2012) and is, therefore, an important issue in the food industry (Nasri, 2017). 
Oxidation of unsaturated lipids in food results in formation of off-flavours and undesirable 
odours, but also decrease the nutritional quality and lead to formation of  potentially toxic 
compounds (Farvin et al., 2014). Synthetic antioxidants are used today, but their use is under 
strict regulation because of their potential health risks (Farvin et al., 2014) connected with 
toxicity, protein and DNA damage and side effects (Chi et al., 2015). Therefore, a search for 
new and safe antioxidants from natural origin has gained great interest in recent years (Sila & 
Bougatef, 2016). 
Currently there is no single assay that is able to evaluate the overall antioxidative potential of a 
compound, because oxidative processes are complex and different mechanisms can protect 
biological system from free radicals (Sveinsdottir et al., 2014). Sveinsdottir et al. (2014) classify 
these mechanisms into five categories:  
(1) inhibition of generation and scavenging properties against free radicals, 
(2) reducing ability, 
(3) metal-chelating capacity,  
(4) activity as antioxidative enzymes, 
(5) inhibition of oxidative enzymes.  
Over 20 assays have been developed to evaluate the antioxidant activities of compounds (Hayes 
& McKeon, 2014). Among them the most often methods used to evaluate the antioxidant 
potential of marine food compounds are oxygen radical absorbance capacity (ORAC) assay, 
2,2-diphenyl-1-picrylhydraxyl (DPPH) radical-scavenging capacity assay, Trolox equivalent 
antioxidant capacity (TEAC) assay, ferric-reducing antioxidant power (FRAP) assay, and total 
radical-trapping antioxidant parameter (TRAP) assay (Sveinsdottir et al., 2014).  
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ORAC assay is the most common assay in research, clinical and food laboratories. In the ORAC 
assay a component is tested on its ability to quench free radical by hydrogen donation to form 
a stable compound and thus stop radical chain reaction (Sveinsdottir et al., 2014). The main 
principles of the ORAC assay were developed by Glazer (1988) and later the assay was 
improved by Ou, Hampsch-Woodill, & Prior (2001) who proposed to use fluorescein as the 
fluorescent probe. The ORAC assay measures antioxidant scavenging activity against peroxyl 
radical induced by AAPH (2,2′-Azobis(2-methylpropionamidine) dihydrochloride). Caused by 
the exposure to free radicals, fluorescent molecule fluorescein losses fluorescence. 
Antioxidants can protect fluorescein from damage and the protective effect is evaluated based 
on a fluorescence intensity measured by a fluorometer (Ou et al., 2001). The ORAC assay 
measures antioxidant capacity of substrates and combines inhibition time and degree of 
inhibition into a single measurement (Huang et al., 2002).  
1.2.4.3 Anti-inflammatory assay 
Inflammation is a reaction of the innate defense system to tissue injury caused by a pathogen 
or wound. During the acute inflammation (the immediate response to cell death or injury) the 
cells from the injured tissue initiate a cascade of events by releasing inflammatory mediators. 
Chronic inflammation can develop if inflammatory pathways are stimulated for a long period 
of time (Willey et al., 2014). However, uncontrolled and chronic inflammation can lead to 
development of diseases, such as rheumatoid arthritis, cardiovascular diseases, asthma (Ahmad 
et al., 2019), diabetes, atherosclerosis, and cancer (Subhan et al., 2017). Steroidal and non-
steroidal anti-inflammatory drugs are used for management of inflammation, but both types of 
drugs can cause serious side effects (Ahmad et al., 2019). Therefore, there is a focus to find 
new anti-inflammatory compounds. 
Cell-based assays are used to evaluate anti-inflammatory properties of a test compound. 
Macrophages play an important role in host defense systems and activated macrophages 
regulate inflammation by inflammatory cytokines (e.g., TNF-α and interleukins (IL)) (Joshi et 
al., 2016). Thus, one of the potential approaches to treat inflammatory diseases is by inhibition 
of production of pro-inflammatory mediators (Subhan et al., 2017). Macrophages activated by 
lipopolysaccharides (LPS) are used to study inflammation in vitro (Rocha et al., 2018).  
Anti-inflammatory assay can evaluate the ability of a test compound to inhibit production of 
TNF-α by LPS activated macrophages. First, Thp-1 cells are stimulated by PMA (phorbol 12-
myristate 13-acetate) to differentiate from monocytes to macrophages. Then the cells are 
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incubated with the test compound followed by addition and incubation with LPS. The amount 
of TNF-α produced can be detected and quantified by Sandwich ELISA (enzyme-linked 
immunosorbent assay). 
The principle of ELISA technique is based on the the binding affinity and specificity of 
antibodies (Nelson & Cox, 2013). Sandwich ELISA is a several stage process. First, ELISA 
plates are coated with human TNF-α antibodies (capture antibodies) followed by addition of 
test samples (antigen) and standards. Then biotin conjugated human TNF-α Ab (detection 
antibodies) binds to a test sample or standard forming a antibody-antigen-antibody sandwich. 
Afterwards, biotin binds to Extravidin, which is congugated to alkaline phosphatase (enzyme). 
When alkaline phosphatase reacts with chromogenic substrate pNPP, yellow color is generated, 
thus detecting TNF-α presence (Figure 14). The color intensity is measured by 
spectrophotometer at 405 nm (Biosciences, n.d.; Crowther, 2001).  
 


















1.3 Aim of the project 
The main aim of the project is to evaluate enzymatic hydrolysis of and hydrolysates from 
Atlantic cod (G. morhua) heads. 
Sub-goals are: 
1) Evaluate and compare the yield and molecular weight of peptides of the individual 
hydrolysates from muscle, skin and bone from cod heads by using 23 different 
proteases. 
2) Identify proteases that are selective towards myofibrillar proteins or collagen, by 
calculating selectivity ratio based on hydrolysate yield. 
3) Evaluate and document the bioactivities of the hydrolysates based on antioxidative, 
viability, anti-inflammatory in vitro assays. 




2 Materials and methods 
2.1 Raw material  
Heads from Atlantic cod (Gadus morhua) obtained from Brødrene Karlsen AS (Husøy, Senja, 
Norway), were used as raw material. The fish was caught in spring 2019. The cod heads were 
transported and stored frozen (-24℃) until start of the experiments.  
2.2 Enzymes and other chemicals 
Enzymes (all proteases), their optimal working conditions and their price range are listed in 
Table 2. All other chemicals used in the experiments were of analytical grade and are listed in 
Appendix A 1 Table 6.  








Alcalase AF 2.4 L 8.0-9.5 65-75 Low  Novozymes A/S, Bagsvaerd, Denmark 
Bromelain 4.0-8.0 45-60 Medium  Gunung Sewu Group, Jakarta, Indonesia 
Corolase 2TS 7-8 (6-9) 65 Medium AB Enzymes GmbH, Darmstadt, Germany 
Corolase 7090 6.5-7.5 45-70 Low AB Enzymes  
Tail 10 9 (5-9) 30-65 Low Tailorzyme ApS, Søborg, Denmark 
Tail 189 8 (5-9) 45 High  Tailorzyme  
Tail 190 9 (5-9) 30-60 High Tailorzyme  
Tail 191 7 (6-8) 55 High Tailorzyme  
Tail 192 7 (6-8) 30-55 High Tailorzyme  
Tail 193 8 (5-9) 45 High Tailorzyme  
Tail 194 7 (6-9) 60 High Tailorzyme  
Tail 197 7 50 High Tailorzyme  
FoodPro 30L 8.0-9.5 45-65 n.d.a.*** DuPont Danisco, Copenhagen, Denmark 
FoodPro 51FP 8.0-10.0 45-60 High DuPont Danisco 
FoodPro PNL 6.5-7 55-65 Low DuPont Danisco 
Veron L10 5.5-8.0 55-65 n.d.a. AB Enzymes  
Flavourzyme 5.0-7.0 50 High Novozymes  
Protamex 5.00-11.0 60 Medium Novozymes  
Promod 144GL 5.0-7.0 50-60 n.d.a Biocatalysts Ltd., Cardiff, UK 
Promod P950L 5.0-7.0 50-60 n.d.a Biocatalysts  
Endocut 01 6.0-8.0 45-55 Low Tailorzyme  
Endocut 02 9-10 60 Low Tailorzyme  
Endocut 03 7-10 55-70 Low Tailorzyme  
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* Taken from Product Data Sheets of individual enzymes provided by manufacturer or distributer 
** Provided by Tailorzyme ApS: 
High is price range from €40 to €120 per kg of enzyme 
Medium is price range from €25 to €40 per kg of enzyme  
Low is price range from €15 to €25 per kg of enzyme 
***n.d.a. no data available 
2.3 Workflow of the experiment   
This master thesis is part of the Notably project. The main contribution of this thesis is the  
investigation of the enzymes that are specific for myofibrillar proteins in muscle tissue and 
collagen in skin and bones, which is the first step in development of cascade technology. 
Bioactivity testing of the hydrolysates is an additional contribution. The general workflow of 
the experiment is visualized in Figure 15. 
 
Figure 15 – Schematic workflow of the experiment. 
 
2.4 Preparation of cod heads  
Frozen cod heads, with a weight of 950 g to 2600 g, were thawed overnight in a cold room 
(12℃) and then washed in cold water. Three types of material were prepared: skin, muscle and 
bone. Skin was cleaned from scales, muscle and connective tissue, then washed in cold water 
and cut into small pieces (ca. 0.5×0.9 cm) using scissors. Muscle was removed from heads, 
washed in cold water and then cut into small pieces (ca. 0.5×0.9 cm) with a knife. Bones were 
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cleaned from muscle and connective tissues with a knife and a brush, washed with cold water 
and cut into smaller pieces with the help of scissors and pliers. The precut pieces of bone were 
stored frozen (-24℃) until they were crushed using a commercial blender (Waring Commercial 
Inc., Torrington, USA). The precut skin, muscle and crushed bones (5±0.2 g) were weighed 
into 25 mL tubes. The tubes were stored frozen at -24℃ until hydrolysis.  
2.5 Chemical analysis of the raw material 
The chemical composition of muscle, skin and bone from the cod heads was determined by 
measurement of dry matter and ash content. The measurements were performed in 
quadruplicate (ap. 5 g of material per replicate). First, dry matter was identified by drying the 
muscle, skin and bone in a heating cabinet at 110℃ until a stable weight was reached. Then the 
samples were placed into a high temperature oven overnight at 500℃. Dry matter weight and 
ash weight were recorded and difference in weight between dry matter and ash, wet weight and 
dry weight was calculated. 
2.6 Preparation of the hydrolysates  
Three types of material (skin, muscle, bone) were hydrolyzed using 23 protease enzymes, and 
a control treatment without addition of enzyme (Milli-Q water instead of enzyme) was 
performed. The procedure of hydrolysis was performed in the same way for each sample. 
Hydrolysis was performed in duplicate and control treatment was made in quadruplicate. 
Approximately 5 g of material in 25 mL tubes (Sarstedt, Mawson Lakes, Australia) were 
thawed in a cold-water bath for ca. 1 hour. Afterwards, each tube was filled with Milli-Q water 
(21.1 or 21.2 mL, volume was dependent on enzyme). The total liquid volume of water and 
enzyme was 21.25 mL. Each tube was shaken to evenly distribute the material in the water. The 
tubes were placed in a warm water bath (HETO-DAN ApS, Broenderslev, Denmark) at 45℃ 
for 22 min to prepare the samples for hydrolysis. Afterwards, enzyme (1% w:v or w:w) was 
added into each tube: for enzymes in liquid form – 50 µL and in powder form – 150 µL (due to 
dilution of 0.05 g in 150 µL of Milli-Q water). Vortex was used to help dissolve powder 
enzymes in water. The tubes with enzymes were placed onto a nutating mixer (VWR 
International, Radnor, USA) in a heating cabinet (42℃). The hydrolysis proceeded for one hour 
followed by enzyme inactivation by brief microwaving (7 sec) and then hot water bath (ca. 
95℃) for 15 min. Immediately after inactivation, the tubes with samples were centrifuged for 
10 min at 4℃ and 3000 rpm, to achieve separation of sediment and the liquid phase 
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(hydrolysate). The hydrolysates were filtered using Whatman No. 41 filter paper (GE 
Healthcare Life Sciences, Buckinghamshire, UK), weighed, placed into a freezer (first at -24℃ 
for storage and later at -78℃ as preparation for freeze drying) and then freeze-dried in a freeze 
dryer FreeZone 12 (Labconco, Kansas City, USA). The weight of the freeze-dried hydrolysates 
was registered. The remaining sediment in the tubes and on filter papers were placed into 
heating cabinets for drying at 110℃ and 62℃ respectively. When stable weight was achieved 
the weight of dried material was registered. For analysis and comparison of the results, the 
weights were adjusted per 5 g (an example of calculation is presented in Appendix A 2.1.). 
Calculations of total yield and hydrolysate yield were done using the formulas below (an 
example is presented in Appendix A 2.2.).  
(1) control treatment yield or background reaction (protein dissolved in water; no enzyme 
added) = (
𝑓𝑟𝑒𝑒𝑧𝑒−𝑑𝑟𝑖𝑒𝑑 ℎ𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑎𝑡𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 𝑓𝑜𝑟 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 (𝑔)
𝑑𝑟𝑦 𝑚𝑎𝑡𝑡𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 (𝑔)
)  × 100% 
(2) total yield = (
𝑓𝑟𝑒𝑒𝑧𝑒−𝑑𝑟𝑖𝑒𝑑 ℎ𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑎𝑡𝑒 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝑑𝑟𝑦 𝑚𝑎𝑡𝑡𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 (𝑔)
)  × 100% 
(3) hydrolysate yield (%) = total yield (%) – background reaction (%) 
Also, the theoretical maximum hydrolysate yield was calculated for each type of raw material 
using the formulas for the hydrolysate yield. In the calculations, the amount of organic matter 
in the raw materials was considered as ‘freeze-dried hydrolysate weight’ and an assumption 
was made that all organic matter consisted only of proteins. 
Calculations of sediment reduction due to enzymatic hydrolysis were done using the formulas 
below (an example is presented in Appendix A 2.3.).  
(1) control treatment sediment or background reaction sediment = 
(
𝑠𝑒𝑑𝑖𝑚𝑒𝑛𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 𝑓𝑜𝑟 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 (𝑔)
𝑑𝑟𝑦 𝑚𝑎𝑡𝑡𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 (𝑔)
)  × 100% 
(2) total sediment = (
𝑠𝑒𝑑𝑖𝑚𝑒𝑛𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝑑𝑟𝑦 𝑚𝑎𝑡𝑡𝑒𝑟 𝑜𝑓 𝑡ℎ𝑒 𝑚𝑎𝑡𝑒𝑟𝑖𝑎𝑙 (𝑔)
)  × 100% 
(3) sediment reduction (%) = total sediment (%) – background reaction sediment (%) 
Based on hydrolysate yields, skin/muscle and bone/muscle selectivity ratios were calculated 
(an example is presented in Appendix A 2.4.). 
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2.7 Determination of molecular weight  
2.7.1 Size exclusion chromatography 
The molecular weight of peptides in the hydrolysates were determined by size exclusion 
chromatography (SEC). SEC was performed using Shimadzu Prominence high-performance 
liquid chromatograph (HPLC) (Shimadzu, Kyoto, Japan). LabSolutions GPC software 
(Shimadzu) was used to calculate weight average MW of the hydrolysates, an example of 
calculation of weight average MW is shown in Appendix A 2.5. Freeze-dried hydrolysates were 
dissolved in a mobile phase (Acetonitrile: H2O: Trifluoroacetic acid in the ratio 30:70:0.05) to 
get concentration at 20 mg/mL followed by centrifugation for 1 min. Subsequently the solutions 
(100 µL) were pipetted into vials and placed into a sampler. The injection volume was 10 µL 
and the separation was performed using a BioSepTM 5 μm SEC-S2000 145 Å LC column 
300×7.8 mm. Every 7th sample was a blank to control for possible cross-contamination of the 
samples.  
2.7.2 SDS-PAGE 
The molecular weight of the hydrolysates and of the control treatment made from skin was also 
estimated by SDS-PAGE. First, an appropriate concentration of freeze-dried hydrolysates for 
running of SDS-PAGE was determined by testing several concentrations on three samples 
(control, hydrolysates with high and low average MW). The protein amount tested with 
hydrolysates were: 50 µg, 100 µg, 200 µg, 250 µg and 500 µg per well; and with the control 
treatment were: 25 µg, 50 µg, 100 µg and 200 µg per well. Electrophoresis was carried out 
using a precast NuPAGE 12% Bis-Tris gel (Invitrogen, ThermoFisher Scientific, USA), and 
premixed buffers: MOPS SDS Running buffer (Invitrogen) and NuPAGE LDS Sample Buffer 
(Invitrogen). Two MW markers were used to determine approximate molecular weight of the 
samples: HiMARK Pre-stained Protein standard (Invitrogen) and SeeBlue Plus2 Prestained 
standard (Invitrogen). The freeze-dried samples were diluted in distilled water and 20% of the 
sample buffer to get a concentration at 25 mg/mL for hydrolysates (~250 µg protein per well) 
and 5 mg/mL for the control treatment (~25 µg protein per well).  The resulted mixtures were 
briefly vortexed and heated to 50℃ for 10 min on a heated block (Gant, Kisker Biotech, 
Germany). Afterwards, the samples and MW markers were loaded on the gel. Electrophoresis 
was performed for 50 min at 1.5 Ampere and 200 Volt using XCell SureLock Mini-Cell XCell4 
chamber system (Invitrogen). After electrophoresis, the gels were washed with water, placed 
into a container filled with water and heated in the microwave for ca. 30 sec followed by 
changing of water (3 times in total). Then the gels were covered with a staining reagent 
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SimplyBlue SafeStain  (Invitrogen), heated in the microwave for ca. 30 sec and placed onto a 
rocking platform (VWR) for 1 hour at 40 rpm followed by washing the gels in water and 
keeping them in water overnight. Afterwards, photos of the gels were taken for analysis. 
2.8 Bioactivity testing 
An evaluation of the bioactivity of the freeze-dried hydrolysates made from muscle, skin and 
bone was performed. Three assays were made to test for antiproliferative, antioxidant and anti-
inflammatory properties. The test concentration for each assay was determined based on a 
literature review and consideration that crude hydrolysates were tested. A preliminary 
concentration test of three hydrolysates per material at several concentrations (0.1, 1, 10 and 
100 µg/mL) was done for the antioxidant assay; and a preliminary testing of two hydrolysates 
per material at several concentrations (25, 50, 100, 250 and 500 µg/mL) was done for the anti-
inflammatory assay.  
2.8.1 Viability assay 
An Aqueous One Solution Cell Proliferation assay was performed to evaluate antiproliferative 
properties of the hydrolysates against human melanoma cells. 
Cell culture maintenance: splitting and seeding  
Human melanoma cells (cell line A2058) were grown at 37℃ and 5% CO2. First, cell culture 
was prepared for seeding. Growth medium (DMEM supplemented with 1% L-alanyl-L-
Glutamin, 10% FBS and 0.1% Gentamycin), phosphate buffered saline (PBS) and trypsin were 
pre-warmed to 37℃. Growth media was removed, and cells were washed with PBS for ca. 1 
min followed by trypsinization. Afterwards, cells were resuspended in growth media (ca. 10 
mL). Then 1 mL of the cell suspension was pipetted into a new flask and placed into a Heracell 
VIOS 160i CO2 incubator (Thermo Fisher Scientific, MA, USA) at 37℃ and 5% CO2 for 
culture maintenance and the remaining volume was used for seeding. Cell number in the cell 
suspension for seeding was estimated by mixing Trypan blue (100 µL) with the cell suspension 
(100 µL). Bürker counting chamber was used to count cells in 10 µL under microscope (Leica 
Microsystems GmbH, Germany) followed by calculation of cell suspension volume and volume 
of media to get the desired cell density (2000 cells per well for 72-hour incubation) and volume 
for seeding. Cell suspension (100 µL) was added to each well in 10 microtiter plates (Nunclon 
Delta Surface, Thermo Fisher Scientific). Afterwards, the plates were placed into Heracell 
VIOS 160i CO2 incubator at 37℃ and 5% CO2 for 24 hours. 
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Cell Proliferation assay, reading and results evaluation 
Freeze-dried hydrolysates (150 in total) were diluted in distilled water a day before addition 
and were stored at 4℃; start concentration was 10 mg/mL making the final concentration 1 
mg/mL. After 24-hours incubation, the cells were ready for addition of the hydrolysate 
solutions. First, the cells were inspected under the microscope, growth media was removed and 
fresh media (90 µL) was added. Then the hydrolysate solutions (tested at 1 mg/mL; 10 µL) 
were added in triplicate. Growth media was negative control and 10% DMSO was positive 
control. After the addition, the microtiter plates were incubated for 72 hours at 37℃ and 5% 
CO2. 
After 72-hour incubation, Aqueous One Solution (10 µL) was added into each well followed 
by 1-hour incubation at 37℃ and 5% CO2. Then the plates were ready for measurement of 
absorbance at 485 nm by the DTX 880 Multimode Detector (Beckman Coulter, Brea, 
California, USA).  The results were analyzed in Excel. Percent of survival was calculated as 
𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 % =  
(𝑂𝐷 𝑡𝑒𝑠𝑡 𝑤𝑒𝑙𝑙 − 𝑂𝐷 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙)  × 100
𝑂𝐷 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − 𝑂𝐷 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 
2.8.2 Antioxidant assay 
Antioxidant properties of the hydrolysates were analyzed using the oxygen radical absorbance 
capacity assay. 
All reagents were diluted in 75 mM phosphate buffer (pH 7.4), except for freeze-dried 
hydrolysates, which were diluted in Milli-Q water. The assay was performed using black 
MaxiSorp™ plates (VWR International, Radnor, USA). The final assay mixture volume was 
210 µL. First, the hydrolysate samples were pipetted into the wells (21 µL, start concentration 
500 µg/mL) followed by distilled water (4 µL). Wells with Trolox standard (25 µL; standard 
curve 18 – 12.5 – 6.25 – 3.13 – 1.57  – 0 µM) and blank wells (210 µL phosphate buffer) were 
prepared as well. Then fluorescein (125 µL, 55 nM) was added into each well. The plates were 
incubated for 15 min at 37℃. After incubation, AAPH (60 µL, 54 mg/mL) was added and the 
plates were placed into a plate reader Victor 3 (PerkinElmer, Waltham, MA, USA), which 
recorded 25 measurements of fluorescence at 1 min intervals. All reaction mixtures were 
prepared in duplicate. A template in Excel was used to analyze the raw data. First, fluorescence 
measurements were normalized to the blank measurements. Then the area under the 
fluorescence curve was calculated. The hydrolysate sample values were expressed as Trolox 
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equivalents, calculated based on the Trolox standard curve calculated for each plate. Formulas 
are presented in Appendix A 2.6. 
2.8.3 Anti-inflammatory assay 
Anti-inflammatory activity of the hydrolysates was evaluated based on the anti-inflammatory 
assay using LPS stimulated human macrophages and measuring the expression of TNF-α. The 
amount of TNF-α in the samples were determined by ELISA. 
Cell culture: splitting and seeding 
Human monocyte cell line THP-1 was grown at 37℃  and 5% CO2 in RPMI media 
supplemented with 10% FBS (ultralow endotoxin). Cell culture from Nunc Easy flask (Thermo 
Fisher Scientific) was transferred into 50 mL centrifuge tube and centrifuged for 5 min at 150 
g. Afterwards, the old media was removed and fresh pre-warmed (37℃) media (25 mL) was 
added. Cell density was calculated using Bürker counting chamber: first, cell suspension (50 
µL) was mixed with trypan blue (450 µL) and then 10 µL was pipetted onto a counting chamber. 
Afterwards, volumes of growth media and cell suspension were calculated and mixed together 
to get cell density of 106 cells per mL. PMA (50 ng/mL) was added to the cell suspension to 
stimulate differentiation of monocytes into macrophages. Cell suspension (100 µL) was 
pipetted into separate wells of the microtiter plates (VWR International) and the plates were 
placed into an incubator at 37℃ and 5% CO2 for 48 hours. After 48-hour incubation, cells were 
inspected under microscope followed by removal of old media, then cells were washed with 
pre-warmed PBS and fresh media was added. The plates were placed back into an incubator for 
another 24 hours.  
 
Addition of test samples 
After the incubation, cells were ready for addition of the hydrolysates. The freeze-dried 
hydrolysates were diluted in distilled water to make start concentration at 1 mg/mL, making 
final concentration at 100 µg/mL. Old media was removed and 80 µL of fresh media was added 
in the test wells, 90 µL of media was added into the wells for LPS control and 100 µL of media 
– into the wells with cell control. The hydrolysate solutions (10 µL) were added into the test 
wells in duplicate and incubated for 1 hour at 37℃ and 5% CO2. Then LPS solution (10 µL; 
cells were exposed to 10 ng/mL LPS) was added to each well, except for the cell control. 
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Following a 6-hours incubation at 37℃ and 5% CO2, the plates were stored at -80℃ until 
analysis with ELISA. 
Evaluation of TNF-α expression with ELISA 
Nunc Maxisorp 96F-well ELISA plates (VWR International) were coated with antibodies 
‘Anti-Human TNF alpha Purified’ diluted to 2 μg/mL in 10 mM TBS pH 7.4. Antibody solution 
(100 µL) was added into each well followed by overnight incubation at 4℃.  
The next day washing buffer, blocking buffer, assay diluent and human TNF-α solution (1000 
pg/mL, diluted in assay diluent) were prepared (Appendix A 1: Table 7). The coated plates were 
washed (4 times) with washing buffer using Aquamax 2000 microplate washer (VWR 
International) followed by addition of blocking buffer (200 µL) and incubation for 1 hour at 
room temperature and shaking (300 rpm). The plates were washed again 4 times with washing 
buffer and were then ready for addition of the test samples from the anti-inflammatory assay 
plates. The total volume in each well was 100 µL: wells with test samples and LPS control had 
1:20 dilution in assay diluent from the respective wells of the anti-inflammatory assay; wells 
for cell control had 1:2 dilution in assay diluent; wells with TNF-α standard had a human TNF-
α dilution series (standard curve 1000 – 500 – 250 – 125 – 62.5 – 31.3 – 15.6 – 0 pg/mL). Then 
the plates were incubated for 2 hours at room temperature and shaking (300 rpm) followed by 
washing of the plates by Aquamax 2000.  
After the wash, 100 µL of Anti-Human TNF alpha Biotin (diluted in assay diluent to 3 µg/mL) 
was pipetted into each well and the plates were incubated for 1 hour at room temperature and 
shaking (300 rpm). The plates were washed by Aquamax 2000. Then 100 µL of ExtrAvidin-
Alkaline Phosphatase solution (1:20000 dilution in assay diluent) was added into each well and 
the plates were incubated for 30 min at room temperature and shaking (300 rpm). After the 
incubation, the plates were washed by Aquamax 2000 using program ‘ELISA soak wash’, 
where plates were soaked for 30 sec in each wash step. Then 100 µL of pNPP substrate solution 
was added into each well. The plates were incubated for 45 min at room temperature. After the 
incubations, the plates were placed into DTX880 plate reader (Beckman Coulter) to measure 
OD values at 405 nm. The results were calculated using the equation for the standard curve in 
Excel and analyzed using the following cut-off values: Active > 50% inhibition; 40% < 
Questionable < 50% inhibition and Inactive < 40% inhibition. 
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2.9 Scale-up of the hydrolysis process: theoretical approach  
Promising proteases were selected for hydrolysis on a larger scale based on the hydrolysis 
results of 23 protases. Three enzymes per material were chosen based on the selectivity ratio, 
the highest hydrolysate yield and the highest hydrolysate yield among non-Tail enzyme (due to 
economic considerations). The antioxidant activity of the hydrolysates was also taken into 
consideration. There were enzymes with high antioxidant activity among the selected enzymes 
for muscle and bone, but not for skin.  Therefore, an additional enzyme was chosen for skin, 
which had high results in antioxidant activity and good hydrolysate yield. The hydrolysis with 





The project’s focus is selective utilization of myofibrillar proteins and collagen from residual 
raw material of Atlantic cod heads. The effectiveness of 23 proteases to hydrolyze proteins in 
Atlantic cod heads (skin, muscle and bones) were evaluated and compared  based on yield, 
weight of sediment, selectivity ratio,  average MW and MW distribution of some hydrolysates. 
The bioactive properties of the hydrolysates were also evaluated by viability, antioxidative and 
anti-inflammatory assays.  
3.1 Chemical composition of muscle, skin and bone 
The chemical composition of three main materials of Atlantic cod heads is presented in Table 
3. As the table shows, skin and muscle had similar proportions of water, dry matter and ash 
content. As expected, bone had a considerably lower percentage of water and dry matter but a 
higher percentage of ash content in comparison to skin and muscle. Skin had the highest organic 
matter content at 20%, while bone had 18.5% and skin only 16%. 
Table 3 – Chemical composition of raw material: skin, muscle and bone. The percentage is an average of 
quadruplicate and the weight of raw material was adjusted per 5 g for comparison. 
Material Water (%) Dry matter (%) Ash content (%) Organic matter* (%) 
Skin 78.60 21.40 1.26 20.14 
Muscle 83.11 16.89 0.92 15.96 
Bone 47.47 52.53 34.03 
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3.2 Yield of enzymatic hydrolysis 
Hydrolysate yield from three types of material is presented in Figure 16. The hydrolysates made 
from muscle had higher hydrolysate yield compared to the hydrolysates produced from skin or 
bone; and the hydrolysates from bones had the lowest yield (based on the total yield 
hydrolysates from skin had the highest yield, see Appendix A 3). The weight of freeze-dried 
hydrolysate, total yield and hydrolysate yield can be found in Appendix 3 (for muscle Table 
10, skin Table 11 and bone Table 12). The theoretical maximum hydrolysate yield for the three 
types of material was calculated to 79.4% for muscle, 41.6% for skin and 32.8% for bone 
respectively.  
Among the hydrolysates from muscle, the highest result was 50% made by Tail 191 and the 
lowest result was 20.3% (Flavourzyme). Three hydrolysates with the highest yield were very 
close to each other (50%, 48.6% and 47.6%) and the gap between the third place and the fourth 
was 8.5%. When sorted based on percentage of yield, all 20 hydrolysates starting from the 
fourth place had small differences between two adjacent positions (from 0.08% to 2.7%). 
Among the hydrolysates made from skin, the highest hydrolysate yield was 29.5% (Tail 194) 
and the lowest yield was 6.1% (Endocut 01). When sorted according to the yield percentages, 
no big gaps (0.01-2.45%) were observed between two adjacent positions among the top 20 
hydrolysates. The difference between position 20 (Promod 144GL) and 21 (Veron L10) was 
5.5% and between 22 (Bromelain) and 23 (Endocut 01) – 7.8%. 
Small variation was observed among the hydrolysates made from bones. The highest 
hydrolysate yield was 5.4% (Tail 190), while the lowest was 3% (Veron L10). When sorted 












Figure 16 – Hydrolysate yield for (A) muscle, (B) skin and (C) bone. The amount of protein hydrolyzed by an 
enzyme; the background reaction* is subtracted from the total yield. Results are based on duplicates and the weight 
of raw material was adjusted per 5 g for comparison. 
*proteins solubilized in the control reaction (without addition of enzyme). 
 
3.3 Sediment reduction by enzymatic hydrolysis 
The amount of sediment reduced by enzymatic treatment in comparison to the control treatment 
is presented in Figure 17. The highest reduction of sediment was shown by enzymatic 
hydrolysis of muscle and the lowest – by hydrolysis of bones. The sediment weight is presented 
in Appendix A 3 (Table 10, Table 11, Table 12). 
Variation was observed among the sediments from the hydrolysis of muscle: the highest 
reduction of sediment was 46.3% (Tail 191) and the lowest was 19.9% (Flavourzyme). After 












































































Figure 17 – Sediment reduction due to enzymatic hydrolysis: (A) muscle, (B) skin, (C) bone. Sediment is a sum of 
sediment in the tubes after hydrolysis dried at 110℃ until stable weight and residue on the filter paper dried at 62℃ 
until stable weight. Results are based on duplicates and the weight of raw material was adjusted per 5 g for 
comparison. 
3.4 Selectivity ratio towards collagen and myofibrillar proteins 
The selectivity ratio towards collagen and myofibrillar proteins of the proteases (Table 4) was 
calculated based on the comparison of hydrolysate yields produced from muscle (rich in 






































































The skin/muscle ratio of 22 enzymes was below 1 and the range was from 0.23 to 0.89. Thus, 
most proteases had selectivity (higher hydrolysate yield) towards myofibrillar proteins and 
Endocut 01 showed the highest selectivity ratio. Even though Endocut 01 had produced 
hydrolysates with low yield both from muscle (19th place) and skin (23rd place) (Figure 16), the 
relative difference between the two yields was the biggest in comparison to other samples. Only 
Flavourzyme demonstrated selectivity towards collagen (1.32) due to the lowest yield for 
muscle and 5th highest yield for skin. 
The bone/muscle ratio demonstrated that all ratios were below 1, ranging from 0.09 to 0.18. 
This indicated that all proteases work best on myofibrillar proteins. 




Alcalase  0.68 0.17 
Bromelain 0.58 0.17 
Corolase 2TS 0.57 0.11 
Corolase 7090 0.75 0.12 
Tail 10 0.67 0.13 
Tail 189 0.57 0.09 
Tail 190 0.89 0.18 
Tail 191 0.50 0.10 
Tail 192 0.74 0.14 
Tail 193 0.52 0.12 
Tail 194 0.61 0.10 
Tail 197 0.67 0.12 
FoodPro 30L 0.71 0.12 
FoodPro 51FP 0.77 0.12 
FoodPro PNL 0.61 0.11 
Veron L10 0.64 0.14 
Flavourzyme 1.32 0.15 
Protamex 0.83 0.13 
Promod 144GL 0.80 0.14 
Promod P950L 0.78 0.13 
Endocut 01 0.23 0.13 
Endocut 02 0.67 0.12 
Endocut 03 0.67 0.13 
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3.5 Molecular weight of the hydrolysates 
Average molecular weight determined by SEC 
Molecular weight of the peptides in the hydrolysates were determined by SEC. As Figure 18 
shows, the average MW of hydrolysates produced both from muscle and from bone were lower 
than the average MW of hydrolysates from skin.  
Average MW of hydrolysates produced from muscle ranged from 3564 Da (Flavourzyme) to 
954 Da (Tail 189). When the hydrolysates were sorted according to their average MW, the 
hydrolysate produced by Flavourzyme stood out due to a big difference in comparison to the 
adjacent hydrolysate produced by Endocut 03 (2348 Da).  
Average MW of the hydrolysates produced from skin ranged from 13037 Da (Veron L10) to 
1198 Da (Tail 189). The hydrolysates produced by Veron L10 and Promod 144GL (11230 Da) 
stood out from the other hydrolysates as having peptide with high average MW. The 
hydrolysate that had the next highest average MW was made by Flavourzyme (5803 Da).   
Average MW of the hydrolysates produced from bones ranged from 9731 Da (Veron L10) to 
1065 Da (Tail 189). When the hydrolysates were sorted according to their average MW, the 
hydrolysates produced by Veron L10 and Promod 144GL (6111 Da) differed from the other 
hydrolysates. Both had considerably higher average MW, than the hydrolysate with the third 
highest average MW of 2353 Da (Corolase 2TS). 
The average MW of protein fragments produced by control treatment was also determined by 
SEC. Protein fragments in the control sample from skin had the highest average MW (77309 
Da) in comparison to the control samples from muscle and bone; protein fragments in the 
control sample from muscle had the lowest average MW (17544 Da); whereas protein 
fragments in the control sample from bone had average MW of 39059 Da. The molecular 
weight distribution of the fragments are presented in Appendix A 4 (muscle Table 16, skin 
















Figure 18 – Average molecular weight of peptides determined by SEC: (A) muscle (B) skin, (C) bone; (I) 20 
enzymes, (II) 3 enzymes that produced hydrolysates with higher average MW than others. Peptides are produced 
by 23 enzymes from muscle, skin and bone of cod heads (control treatments without addition of enzyme are not 
present due to high MW values). Results are based on duplicates. 
Molecular weight distribution of some hydrolysates determined by SEC 
Molecular weight distribution of the following hydrolysates was analyzed: the hydrolysates 
with  the highest yield, the hydrolysates with the highest yield among non-Tail enzymes (due 
to economic considerations), and the hydrolysates with the highest and the lowest average MW. 
The MW distribution of some hydrolysates from muscle are presented in Appendix A 4, Table 
13. Comparison of the hydrolysate with the highest yield (Tail 191) and hydrolysate with the 
lowest average MW (Tail 189) showed rather similar MW distribution of the peptides: the 




















































































































































































































































































Da, while the hydrolysate made by Tail 191 had slightly under 80%. The hydrolysate produced 
by Corolase 2TS (the highest yield among not Tail enzymes) had only around 60% of the 
peptides with MW under 1000 Da. The hydrolysate produced by Flavourzyme (with the lowest 
yield and the highest average MW) also had 60% of the peptides with MW under 1000 Da, 
however, it also had ~17% fragments with MW around 15000-16000 Da. 
The MW distribution of some hydrolysates from skin are presented in Appendix A 4, Table 14. 
Comparison of the MW distribution of the hydrolysate with the highest yield (Tail 194) and 
hydrolysate with the lowest average MW (Tail 189) demonstrated relatively similar MW 
distribution: the hydrolysate made by Tail 189 had almost 80% of the fragments with MW 
under 1000 Da, while the hydrolysate made by Tail 191 had 70%. The hydrolysate produced 
by Protamex (the highest yield among not Tail enzymes) had only 24% of the peptides with 
MW under 1000 Da with the majority peptides (~70%) in the range of 1010 Da – 5100 Da. The 
hydrolysate produced by Endocut 01 (lowest yield) had only ~20% of the peptides with MW 
under 1000 Da, most peptides (~67%) had MW in the range from 1020 Da to 5000 Da and 
~11% of peptides had MW  around 15000 Da. The hydrolysate produced by Veron L10 (the 
highest average MW) had almost 60% of fragments with MW around 20500 Da and 33% 
peptides in the range from 1050 Da to 4100 Da. 
The MW distribution of some hydrolysates from bone are presented in Appendix A 4, Table 
15. Comparison of the MW distribution of the hydrolysate with the highest yield (Tail 190) and 
hydrolysate with the lowest average MW (Tail 189) showed some similarities: the hydrolysate 
made by Tail 189 had almost 60% of the fragments with MW under 1000 Da, while the 
hydrolysate made by Tail 190 had 40%; both hydrolysates had peptides with 1020 Da – 1030 
Da (Tail 189: 24% and Tail 190: 31%). The hydrolysate produced by Alcalase (the highest yield 
among not Tail enzymes) had 78% of peptides with MW under 1003 Da. The hydrolysate 
produced by Veron L10 (the lowest yield and the highest average MW) had around 50% of 
peptides with MW of 17100-18000 Da and ~37% of peptides in the range from 1000 Da to 
4100 Da. The hydrolysate produced by Flavourzyme (the lowest yield) had 61% of peptides 






Molecular weight distribution of the hydrolysates made from skin determined by SDS-
PAGE 
The hydrolysates prepared from skin had the highest average MW in comparison to 
hydrolysates from muscle and bone (Figure 18). SDS-PAGE was done using the hydrolysates 
and the control treatment made from skin because the SEC conditions used, with the chosen 
column and calibration proteins (proteins with the highest MW were bovine serum albumin –  
66.5 kDa and albumin from chicken egg white –  42.7 kDa), do not separate peptides with high 
MW into distinct groups. 
The SDS-PAGE showed that most of the hydrolysates had similar patterns with three clearly 
visible bands: one over 200 kDa and two around 100 kDa (Figure 19). The size of the bands 
corresponded to α chains of collagen type I: α1 and α2 have MW of ~100 kDa; and a β 
component (dimer) with MW of ~200 kDa. However, three hydrolysates made by Corolase 
2TS, Veron L10 and Promod 144GL did not have any visible bands. All hydrolysates showed 
‘smear’ (protein fragments with gradually increasing MW) with different color intensity at 
different MW; for example, the hydrolysate prepared by Corolase 2TS had ‘smear’ below 51 
kDa, while the hydrolysate prepared by Flavourzyme had ‘smear’ within the whole lane and 
had a stronger color intensity. The hydrolysates made by Tail 193, Flavourzyme and Endocut 
01 showed several additional bands. The control treatment showed a different pattern in 
comparison to the hydrolysates; it had the highest color intensity in the top of the lane (above 











   MW markers: 
 
   I SeeBlue Plus 2 
   II HiMARK 
 
   Sample treatment: 
   1 Alcalase 
   2 Bromelain 
   3 Corolase 2TS 
   4 Corolase 7090 
   5 Tail 10 
   6 Tail 189 
   7 Tail 190 
   8 Tail 191 
   9 Tail 192 
   10 Tail 193 
   11 Tail 194 











13 FoodPro 30L 
14 FoodPro 51FP 
15 FoodPro PNL 
16 Veron L10 
17 Flavourzyme 
18 Protamex 
19 Promod 144GL 
20 Promod P950L 
21 Endocut 01 
22 Endocut 02 
23 Endocut 03 
24 Control 
 
Figure 19 – SDS-PAGE patterns of fish skin hydrolysates obtained by different protease treatments and control 
treatment (without addition of enzyme). α-chains, β component, γ component and MW standards from two MW 
markers (SeeBlue Plus2 and HiMARK) are noted. Electrophoresis was carried out with 12% Bis-Tris gel, MOPS 











3.6 Bioactivities of the hydrolysates 
The hydrolysates’ bioactivities were evaluated in three assays: viability, antioxidant and anti-
inflammatory. 
3.6.1  Antiproliferative properties of the hydrolysates 
No significant inhibition of human melanoma cells’ growth was observed at test concentration 
of 1 mg/mL (Appendix A 5.3, Table 21). A slight difference was observed among the 
hydrolysates prepared from muscle, skin and bone. In comparison to the negative control 
(growth media) hydrolysates from muscle showed a 109-95% survival rate; hydrolysates from 
skin demonstrated 105-84% and hydrolysates from bone – 113-74%. 
3.6.2 Antioxidant properties of the hydrolysates 
The test concentration for the assay was chosen based on the preliminary testing of several 
concentrations (results are shown Appendix A 5.1 Table 19). Based on the ORAC assay results 
at test concentration of 50 µg/mL, the hydrolysates produced from muscle have higher 
antioxidant activity than the hydrolysates from skin and bone (Figure 20). Antioxidant activity 
of the protein fractions produced by the control treatment was also evaluated. The control 
treatment from bone had the highest antioxidant activity (1.15 µM TE) in comparison to skin 
(0.82 µM TE) and muscle (0.55 µM TE). 
Among the hydrolysates made from muscle, the hydrolysate produced by Tail 194 (4.95 µM 
TE) had the highest activity, while the hydrolysate made by Endocut 01 (2.42 µM TE) 
demonstrated the lowest activity. Among the hydrolysates prepared from skin, the hydrolysate 
made by Tail 189 (2.43µM TE) showed the highest antioxidant activity and the hydrolysate 
prepared by Promod 144GL (0.82µM TE) had the lowest activity. Among the hydrolysate made 
from bones, the hydrolysate prepared by Alcalase (2.36µM TE) demonstrated the highest 












Figure 20 – Oxygen radical absorbance capacity of hydrolysates produced by 23 enzymes and one control 
treatment (without addition of enzyme): (A) muscle, (B) skin, (C) bone. Results are expressed as Trolox equivalents 
(TE). Concentrations of Trolox used to plot standard curve and their equivalents in TE are shown for reference. 
Test concentration was 50 µg/mL. 
3.6.3 Anti-inflammatory properties of the hydrolysates 
The test concentration for the assay was chosen based on the preliminary testing of several 
concentrations (results are shown in Appendix A 5.2, Table 20). The anti-inflammatory 
properties of the hydrolysates were evaluated based on the expression of TNF-α by LPS 
stimulated human macrophages. No anti-inflammatory properties were detected at a test 






















































































































































































































































All hydrolysates from Atlantic cod demonstrated inhibition lower than 30% (Appendix A 5.4,  
Table 22). The cut-off values for anti-inflammatory activity of a sample were:  >50% inhibition 
– active sample, 40% inhibition – questionable and  <30% inhibition – inactive sample. Due to 
natural variation 20% and -20% inhibition can be observed in wells without any active 
compounds, thus, interpreted as 0% inhibition.  
3.7 Suggested method for scale-up of the hydrolysis process 
This part gives a theoretical presentation of how the enzymatic hydrolysis process can be scaled 
up in the lab from 5 g of raw material to 250 g.1 Based on the results of small-scale hydrolysis 
(5 g raw material), three enzymes were chosen for a large-scale hydrolysis (250 g raw material). 
The enzyme #1 was the enzyme chosen based on the selectivity ratio (Table 4), #2 was the 
enzyme with the highest hydrolysate yield (Figure 16) and #3 was the enzyme with the highest 
hydrolysate yield among non-Tail enzymes. When looking at the antioxidant activity (Figure 
20) of the hydrolysates made by these enzymes, the hydrolysate produced from muscle by Tail 
191 had the 3rd highest antioxidant activity, while the hydrolysate from bone made by Alcalase 
had the highest antioxidant activity among the hydrolysates from bone. However, the selected 
enzymes for scale-up for skin made hydrolysates with low antioxidant activity; therefore, an 
additional enzyme was chosen with the 2nd highest results in antioxidant activity and good 
hydrolysate yield (Table 5).  
Table 5 – Enzymes chosen for scale-up, conditions for the experiment and price range of the enzymes. 
Raw 
material 
# Enzyme Temperature (℃) pH Price range* 
Muscle 
1 Endocut 01 45 not adjusted Low 
2 Tail 191 55 not adjusted High 
3 Corolase 2TS 65 not adjusted Medium 
Skin 
1 Flavourzyme 50 not adjusted High 
2 Tail 194 60 not adjusted High 
3 Protamex 60 not adjusted Medium 
4 Endocut 02 60 not adjusted Low 
Bone 
1 Flavourzyme 50 not adjusted High 
2 Tail 190 45 not adjusted High 
3 Alcalase 65 not adjusted Low 
*as defined in Table 2 
 
1 The scale-up was not performed in the laboratory due to the restrictions imposed by corona virus outbreak. 
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The general workflow of this scale-up hydrolysis process (Figure 21) is the same as presented 
for a smaller scale. The main differences are that hydrolysis will be performed at an optimum 
temperature of an enzyme and that the raw material/water proportion will be 1:1 (w/w). 
Additional measurements such as monitoring of the hydrolysis process by SEC at different time 
points of hydrolysis and determination of ash content in freeze-dried hydrolysates and 
sediments will be made. The increase of the raw material only up to 250 g still allows to perform 
the hydrolysis at a laboratory scale, however, some of the equipment will be different. 
 
 




In this project a small-scale hydrolysis of residual raw material from Atlantic cod heads using 
23 proteases was performed. The main aim was to evaluate proteases used to produce 
hydrolysates from different types of raw material of Atlantic cod heads: muscle, skin and bone. 
The evaluation was done based on the hydrolysates’ yield, weight of remaining sediment, 
molecular weight of the hydrolysates, selectivity ratio as well as bioactive properties. Based on 
the evaluation of enzymes, optimum conditions for hydrolysis were suggested for a larger-scale 
hydrolysis process.  
The results showed that the three types of raw material from cod heads had different chemical 
composition, thus different amount of protein for hydrolysis. The hydrolysis with Tail enzymes 
produced the highest hydrolysate yield from all types of raw material. Based on the hydrolysis 
yield and amount of sediment left after hydrolysis, no clear differences were observed in 
performance of most of the enzymes. The selectivity ratio showed that Flavourzyme was the 
only enzyme with selectivity towards collagen, while Endocut 01 had the highest selectivity 
towards myofibrillar proteins. Hydrolysis with different proteases produced hydrolysates with 
different MW profiles. Notably, Tail 189 produced hydrolysates with the lowest average MW 
from all types of raw material.  In general, the hydrolysates made from muscle had the smallest 
average MW, while the hydrolysates from skin had the largest average MW. The SDS-PAGE 
results of the hydrolysates from skin indicated that Tail 193 and Endocut 01 might have 
selectivity towards peptide bonds they cleave, and that Corolase 2TS might be an effective 
protease for cod skin hydrolysis. The bioactivity testing demonstrated that the hydrolysates had 
no antiproliferative or anti-inflammatory activity. However, all hydrolysates demonstrated 
antioxidant activity. The hydrolysates produced from muscle showed higher antioxidant 
activity than the hydrolysates prepared from skin and bone. Also, some variation of the activity 
was observed in the hydrolysates made from the same material but with different enzymes. 
Suggestions for a larger-scale experiment of raw material include: to use several enzymes, the 
choice was based on the selectivity ratio, the highest yield among all enzymes and among non-
Tail enzymes (due to economic considerations) and antioxidant activity; to use optimum 
temperature for each individual enzyme; to monitor progression of the hydrolysis process by 
checking MW of hydrolysates at different time points; and to determine ash content of freeze-




4.1 Evaluation of proteases 
4.1.1  Material from cod heads and yield after hydrolysis 
Atlantic cod head is a complex material, where muscle, skin and bone share a total weight of 
80% (Arnesen & Gildberg, 2006). The evaluation of chemical composition of muscle, skin and 
bone showed that the materials have different characteristics (Table 3). It is also known that the 
materials have different protein composition (Harnedy & Fitzgerald, 2012) and different  
proteins’ accessibility for the enzymes (Arnesen & Gildberg, 2006; Cui et al., 2007). Chemical 
composition of muscle found in this project corresponds well with the results for muscle 
reported by I.-J. Jensen and colleagues (2013) and Shahidi and colleagues (1991). Dry matter 
and water content found in this project for skin are similar to the values reported by Skierka & 
Sadowska (2007) and Arnesen & Gildberg (2007). However, the chemical composition of bone 
determined in this project differed significantly to the chemical composition reported by Toppe 
and colleagues (2007). This variation can be explained by the difference in treatments of bones 
prior to analysis; in the work of Toppe and colleagues (2007) bone pretreatment included 
manual cleaning with knife, boiling to remove remaining muscle and freeze-drying.  
Hydrolysate yield 
Muscle, skin and bone from cod heads were hydrolyzed by 23 proteases under the following 
conditions: 1% enzyme, 1 hour,  42℃, pH not adjusted. Under these hydrolysis conditions, the 
highest hydrolysate yield was produced by Tail 191 from muscle, Tail 194 from skin and Tail 
190 from bone.  
Among the materials (muscle, skin and bone), three general trends were observed: only a slight 
difference in yield produced by the 23 different proteases tested (Figure 16); only a slight 
difference in the amount of sediment left after hydrolysis (Figure 17); and different positions 
(when ranked) of the same samples based on the yield and amount of sediment. These trends 
might indicate that either the testing methods/conditions used are not accurate enough to 
determine differences among the performance of proteases or there are no clear differences 
among the tested proteases. Several possible explanations for the observed results are discussed 
in the following paragraphs. 
One possible explanation is that enzymes work similar in their ability to hydrolyze raw material 
from cod heads under the conditions used. According to the product information of the protases, 
these conditions are not optimal for 20 out of 23 proteases (Table 2). For example, temperature 
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during hydrolysis was 42℃, which is lower than optimal for 20 out of 23 proteases. Only Tail 
10 (30-65℃), Tail 190 (30-60℃) and Tail 192 (30-55℃) have an optimal temperature range 
which includes 42℃. However, seven proteases have an optimal temperature range starting 
from 45℃. Among the remaining proteases, four have an optimum temperature from 50℃, 
another four from 55℃, three from 60℃ and two from 65℃.  
Another possible explanation is – the presence of ash in the freeze-dried hydrolysates, because 
some part of ash is water soluble. The amount of ash in each hydrolysate was not determined 
due to the low weight of the samples. However, it is expected that ash content varies from 
hydrolysate to hydrolysate even from the same type of raw material, thus causing 
overestimation of protein content in the hydrolysates. The suggestion that water soluble mineral 
compounds positively influence the yield of hydrolytes was earlier made by Slizyte and 
colleagues (2005b). They estimated that freeze-dried hydrolysates prepared from a mixture of 
backbones and viscera from Atlantic cod contain 10.6% of ash when prepared by Flavourzyme 
and 9.7% when made by Neutrase (Slizyte et al., 2005b).  
An explanation could be that the exact amount of starting raw material has a significant 
influence when the weight is as low as 5 g. Since raw material is washed in water before 
placement into tubes for hydrolysis, some extra amount of water will negatively influence the 
weight of the raw material. This results into smaller amount of protein substrate for enzymes. 
Also, the determination of sediment weight included several changes of tare and several 
weighings, which might have caused some errors in the final results. Results can also be 
influenced by activity of endogenous enzymes (Hayes & McKeon, 2014; Muralidharan et al., 
2013) and protease inhibitors present in the raw material (Aspevik et al., 2017; Kristinsson & 
Rasco, 2000). 
When comparing the three materials, bone has the lowest hydrolysate yield (Figure 16). The 
explanation might be that bone has high ash content (~34%), as shown in Table 3, and that the 
proteins in the bone are not easily accessible for the proteases due to structural characteristics 
of bones. This has also been pointed out earlier by Arnesen and Gildberg (2006). 
A comparison of the theoretical maximum hydrolysate yields calculated for each type of raw 
material (Section 3.2) and the obtained hydrolysate yields (Figure 16) indicated that not all 
proteins were extracted from all types of raw materials. Along with not optimal hydrolysis 
conditions, other possible explanations can be that some proteins were denatured by heating 
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and denatured proteins are considered to be resistant to enzymatic breakdown; also hydrophobic 
interactions among peptides cause aggregations, which have reduced accessibility for 
enzymatic breakdown (Benjakul et al., 2014; Slizyte et al., 2005a). Skipnes and colleagues 
(2008) determined that the denaturation temperature of collagen in cod skin starts from 32℃, 
whereas cod muscle denaturation starts from 38℃ for myosin, from 57℃ for sarcoplasmic 
proteins and from 76℃ for actin. Slizyte and collegues (2005a) studied hydrolysis of cod 
residual raw materials and reported that the amount of hydrophobic amino acids in non-
solubilized sediment fraction is higher than in the protein hydrolysate fractions, which, they 
suggested,  supported the hypothesis that during hydrolysis hydrophobic amino acids are less 
accessible for enzymatic breakdown due to aggregation. 
4.1.2 Size of peptides in different hydrolysates 
Analysis of average MW (Figure 18) reveals similar tendencies among the hydrolysates 
produced from all three raw materials. The same enzyme (Tail 189) produced hydrolysates with 
the lowest average MW from all materials. This observation could indicate that Tail 189 is a 
universal enzyme with broad specificity. Tail 189 produced hydrolysates with high yield from 
muscle (2nd) and skin (3rd), but not from bone (11th place). The hydrolysates with the highest 
MW also had very low yield for all materials. This could indicate that the enzymes have narrow 
specificity, because proteases have different specificities (Kristinsson & Rasco, 2000), or that 
the hydrolysis conditions were far from optimum.  
In this project, proteases produced peptides with a variety of MW from different raw materials. 
The average MW of the hydrolysates ranged from 954 Da to 3564 Da for muscle, from 1198 
Da to 13037 Da for skin and from 1065 Da to 9731 Da for bone (Figure 18). The variation in 
average MW of hydrolysates produced by different enzymes was expected, because each 
protease has its selectivity towards peptide bonds they can cleave (Walsh, 2014b). It is well-
known that the MW of peptides influences functional properties (Kristinsson & Rasco, 2000) 
and bioactive properties (Fernandes, 2016; Jeon et al., 1999). Therefore, the choice of the 
desired MW of peptides is done based on the desired functionalities of the final product. For 
example, peptides with antioxidant properties have been reported to have MW in the range 
<500 Da up to 1500 Da (Kumar et al., 2012), while the emulsifying and foaming properties of 
peptides increase with the increase of peptides’ MW (Slizyte et al., 2009). The MW of the 
peptides in the hydrolysate depends on the substrate, protease and processing condition 
(Kristinsson & Rasco, 2000; Pal & Suresh, 2016). 
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The hydrolysates and control treatment made from skin were further studied using SDS-PAGE 
because the hydrolysates from skin had the highest average MW in comparison to muscle and 
bone. SDS-PAGE allowed to analyze the MW distribution of protein fragments with high MW 
(>14 kDa). The estimated MW of the bonds present in most of the hydrolysates and the control 
treatment (Figure 19) corresponds well with the MW of α-chains (α1 and α2) of collagen type I 
(ap. 100 kDa each) and higher MW components, possibly γ component (trimer) and β 
component (dimer). The structure of collagen type I – [α1(I)]2 α2(I) (Liu et al., 2012) –  allows 
the distinction between α-chains: α1 has two-fold band intensity comparing to α2. These findings 
are in agreement with previous research on fish skin collagen  (J. Chen et al., 2016; Li et al., 
2013; Liu et al., 2012; Woo et al., 2008; Yu et al., 2018). Analysis of the SDS-PAGE patterns 
of the hydrolysates might indicate that proteases Tail 193 and Endocut 01 have selectivity 
towards peptide bonds they can cleave, because the hydrolysates have several visible bands 
below 97 kDa (Figure 19). While ‘smear’ might indicate that a protease has a broad range of 
peptide bonds it can cleave. 
Three hydrolysates made by Corolase 2TS, Veron L10 and Promod 144GL did not have visible 
bands that corresponds to α-chains. This might indicate that these proteases are more effective 
than other proteases and that they have cleaved all substrate into peptides; or that they have 
hydrolyzed only readily available protein fragments dissolved in the water. Corolase 2TS 
demonstrated the highest reduction of sediment  (Figure 17). This observation could indicate 
that Corolase 2TS might be the most effective out of the enzymes tested, however, Corolase 
2TS had low hydrolysate yield (Figure 16). Veron L10 and Promod 144GL produced 
hydrolysates with low yield and demonstrated low sediment reduction. These observations 
could indicate that these proteases are not optimal for hydrolysis of cod skin. The difference in 
color intensity between the hydrolysate made by Corolase 2TS and the hydrolysates made by 
Veron L10 and Promod 144GL might be explained by the ability of Corolase 2TS to cut 
substrate into low MW peptides (washed away from the gel), while Veron L10  and Promod 
144GL produce more high MW fragments (present in the gel and caused the lane to expand). 
This observation is supported by the average MW of the hydrolysates determined by SEC, 
where the hydrolysates made by Veron L10 and Promod 144GL have the highest and second 





4.1.3 Determination of proteases’ selectivity ratio 
The selectivity ratio was calculated based on the hydrolysate yield (Table 4). The highest and 
lowest ratio showed the biggest relative difference in yield between two substrates. The 
skin/muscle ratio was chosen to determine the enzymes’ selectivity towards collagen and 
myofibrillar proteins. The bone/muscle ratio was not chosen because the limited accessibility 
of collagen in bone for proteases resulted in all ratios being favorable towards myofibrillar 
proteins in muscle. 
Based on the selectivity ratio, Endocut 01 was identified as the enzyme with the highest 
selectivity towards myofibrillar proteins. According to the manufacturer’s product information, 
Endocut 01 is an endo-protease with a broad specificity, and is characterized as a protease that 
efficiently hydrolyzes fish proteins including collagen (Tailorzyme, 2016). Flavourzyme 
showed the highest selectivity ratio towards collagen. Flavourzyme is characterized by the 
manufacturer as a protease with exopeptidase as a key activity which cleaves amino acids at N-
terminal (Novozymes A/S, 2017). 
In general, the skin/muscle selectivity ratio showed that most of the proteases (22 out of 23) 
had selectivity towards myofibrillar proteins. A possible explanation might be in the nature of 
proteins, since myofibrillar proteins and collagen have different amino acids composition and 
different protein structure (accessibility to possible site of peptide bond cleavage) (Parkin, 
1993b). Although, some ratios (e.g. Tail 190, Protamex, Promod 144GL) are close to 1, 
indicating that the activity is similar and independent of the protein nature, which suggests that 
those proteases have broad activity. Another explanation might be in processing conditions 
(Parkin, 1993a), because they were not optimal for the majority of the enzymes and may have 
influenced the performance of enzymes differently. Also, factors that might have influenced 
the hydrolysate yield (discussed earlier in section 4.1.1) consequently could have influenced 
the calculated ratios.  
The biggest relative difference in yield is one approach to determine selectivity. And the highest 
yield can be an alternative approach to look at the selectivity of proteases. The highest yield 
from the three types of raw material was produced by different enzymes, however, all of them 
were Tail enzymes. This finding suggests that Tail enzymes are efficient enzymes in 
comparison to other proteases. However, Tail enzymes have high prices per kg (Table 2) and 
little is known about these enzymes. Therefore, it is also interesting to look at the enzymes with 
known characteristics and with lower prices, which have the highest yield after Tail enzymes. 
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4.2 Assessment of bioactivity 
4.2.1 Antiproliferative properties against cancer cells 
No significant inhibition of human melanoma cells’ growth was observed at test concentration  
1 mg/mL (Appendix A 5.3, Table 21). However, antiproliferative activity of protein 
hydrolysates from Atlantic cod on human breast cancer cell lines has been reported by Picot et 
al. (2006). The difference can be explained by several factors. The first factor is that different 
cell lines were used for testing. And different types of cancer cells may vary in cell membrane 
composition, fluidity and surface area (Song et al., 2011). The second factor is that hydrolysates 
were prepared by different processing methods; as Hsu et al. (2011) reported, hydrolysis for 
different time periods resulted in different antiproliferative activity (including no activity) on 
human breast cancer cell lines. Another factor is batch to batch variation in raw material. Picot 
et al. (2006) observed antiproliferative activity in three out of five hydrolysates produced from 
blue whiting (hydrolysates produced by the same method). 
A number of research articles report antiproliferative activity of fish protein hydrolytes on 
different cancer cell lines (Halim et al., 2018; Hsu et al., 2011; Naqash & Nazeer, 2010; Pan et 
al., 2016; Song et al., 2014; Yaghoubzadeh et al., 2020) where a correlation was observed 
between antioxidant and anticancer properties: some peptides with antioxidant properties also 
possess antiproliferative properties (Nwachukwu & Aluko, 2019). Since the hydrolysates 
demonstrated antioxidative properties in this project several additional factors could have 
contributed to the negative antiproliferative results against cancer cells. These factors could be: 
testing of crude hydrolysate and not purified fractions as was done by e.g. Naqash & Nazeer 
(2010) or Yaghoubzadeh et al. (2020); or low test concentration. In this project test 
concentration was as high as 1 mg/mL, while the test concentration used by e.g. Song et al. 
(2011) was ranging from 5 to 40 mg/mL. However, high concentrations of any compound can 
disrupt the cell functionality and be cytotoxic (Kisitu et al., 2019) (Cronk, 2013), thus giving a 
false positive result (not caused by a peptide with antiproliferative activity). 
As other bioactivity, the antiproliferative properties of protein hydrolysates are considered to 
be influenced by MW and amino acid composition (Pan et al., 2016). Cationic amino acids are 
reported to be crucial for the antiproliferative activity of peptides because cationic peptides can 
interact strongly with the anionic components on cell membranes and thus would disrupt tumor 
cells (Song et al., 2014). 
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4.2.2 Antioxidant properties 
The hydrolysates from all three materials and from the control treatments (without addition of 
enzyme) demonstrated antioxidant activity (Figure 20). These results are in accordance with 
previous research  (Farvin et al., 2014, 2016; Girgih et al., 2015; Godinho et al., 2016; Jamnik 
et al., 2017; I. Jensen & Mæhre, 2016; Pampanin et al., 2016; Slizyte et al., 2009). The exact 
mechanism of antioxidant activity of some peptides is not fully understood, however, there are 
several hypotheses that try to explain the antioxidant activity of protein hydrolysates (Alemán 
& Martínez-Alvarez, 2013). These hypotheses can be summarized to:  
(1) presence of specific amino acids: such as amino acids with aromatic side chains 
(tryptophan, tyrosine, phenylalanine, histidine), sulfur-containing side chains (cysteine 
and methionine), hydrophobic amino acids (valine, leucine, alanine), proline, and lysine 
(M. Chalamaiah et al., 2012; Chi et al., 2015; Sarmadi & Ismail, 2010)  
(2) abundance of specific amino acids, for example glycine and proline in collagen; 
(3) position of certain amino acids within the sequence; 
(4) hydrophilic and hydrophobic partitioning in the peptide sequence; 
(5) molecular weight of the peptides; 
(6) peptide conformation (Alemán & Martínez-Alvarez, 2013). 
Results show that the hydrolysates from muscle demonstrate higher antioxidant activity than 
the hydrolysates from skin and bone. The difference can be explained by different amino acid 
composition in myofibrillar proteins (muscle) and in collagen (skin and bone). A variation in 
the antioxidant activity among hydrolysates from the same material was also observed. This 
observation can be explained by the MW of the peptides (longer peptides can fold and bury 
hydrophobic amino acids inside) and enzyme specificity (where enzyme cuts and which amino 
acids are exposed). The results also show that hydrolyzed protein have higher activity than non-
hydrolyzed (control treatment). This observation can be explained by exposure of some amino 
acids in peptides, which are usually packed inside proteins (Elias et al., 2008).  
4.2.3 Anti-inflammatory properties 
When the anti-inflammatory properties of the hydrolysates were evaluated, no significant 
decrease in TNF-α expression by LPS stimulated human macrophages was observed at test 
concentration of 100 µg/mL (Appendix A 5.4, Table 22). This result corresponds well with the 
results obtained by Halldorsdottir et al. (2014), who also did not observe an anti-inflammatory 
effect in hydrolysates produced from white muscle of Atlantic cod. However, anti-
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inflammatory peptides have been identified and purified from different protein sources (Ahn et 
al., 2015) including fish: salmon (Ahn et al., 2012), tuna (Cheng et al., 2015), sandfish (Jang et 
al., 2017) and Argentine croaker (Rocha et al., 2018). Studies have identified amino acids that 
have anti-inflammatory properties: glycine, histidine, cysteine, glutamine and tryptophan (Joshi 
et al., 2016). 
No observed decrease in production of proinflammatory cytokines in the present study cannot 
exclude a hypothesis that there were one or several peptides with anti-inflammatory properties 
in the testing samples or that it is possible to produce anti-inflammatory peptides from Atlantic 
cod. Besides the amino acid composition of the raw material, several factors can influence the 
result such as processing method (enzyme, temperature, pre-treatment, duration of hydrolysis, 
pH, etc.); the test concentration of hydrolysates used in the assay; or testing of crude hydrolysate 
instead of fractioned hydrolysates. 
Suggested further experiments  
Based on the results and their evaluation, some follow up experiments can be suggested. Protein 
hydrolysates produced in this project were aimed for human consumption; thus, negative results 
in viability assay against cancer cell line became a good indication that the hydrolysates are not 
cytotoxic. However, a viability assay against non-cancerous human cell line should be 
performed. Antioxidant activity evaluated by ORAC assay was performed using crude 
hydrolysates. Crude hydrolysate is a complex mixture containing peptides of various size; 
therefore, the next step could be to fractionate hydrolysates based on the MW and test these 
fractions to identify MW of peptides with the highest activity. Since the antioxidant compound 
can have different mechanisms of action (Sveinsdottir et al., 2014), it could also be interesting 
to perform other antioxidant assays that detect other antioxidative mechanisms, e.g. ferrozine 
assay (measures metal-chelating capacity). ORAC is a chemical based assay, while cell-based 
assays are considered to be more biologically relevant because they can “address some issues 
of uptake, distribution, and metabolism” (Wolfe & Rui, 2007) of a test compound. Therefore, 
it is relevant to verify the antioxidant potential of the hydrolysates using a cell-based assay such 




4.3 Suggested scale-up process 
This project was a pilot project using small amounts of material from cod heads to evaluate 
different enzymes. The reason for doing it this way was to keep the amount of material and 
enzymes as low as possible to save money and time. This is very often a general approach (K.-
K. Cheng et al., 2007; Neubauer et al., 2013) before suggesting an upscaling process in a 
research lab or in an industrial context. In this project, experiments were performed using 5 g 
of raw material in each reaction, and these small-scale experiments made the basis for 
suggestions for an upscaling to 250 g. The pilot experiment is used to document which enzymes 
to choose for an upscaled process.  
Two main points can be used to explain the need to perform a larger scale lab experiment: (1) 
a deeper understanding of the process, and (2) economic considerations connected with the 
highest yield and prices of the enzymes. Both points are crucial according to the theory of scale-
up processes published by Shinnar (2004).  
The choice of enzymes for an upscaled hydrolysis was based on considerations of selectivity 
ratio, hydrolysate yield, bioactivity and economic considerations. The results made it difficult 
to choose one enzyme per material. Therefore, three enzymes were chosen for muscle and bone, 
and four enzymes for skin (Table 5). Initially, it was planned to use enzymes for a scale-up 
based only on selectivity ratio. However, the selectivity ratio revealed that enzymes selective 
only to collagen or myofibrillar proteins have relatively low hydrolysate yield. Therefore, the 
decision was made to increase the number of enzymes proposed for a scale-up. Notably, Tail 
enzymes were observed to produce the highest yield from different types of raw material. 
However, the chosen Tail enzymes have high prices per kg (Table 2), and price is also an 
important factor when economic viability of the project is assessed. Therefore, Alcalase, 
Protamex and Corolase 2TS, which are often used for hydrolysis of food proteins (Ahn et al., 
2014; Meinlschmidt et al., 2016; Merz et al., 2016), and which also have lower prices and 
demonstrated high hydrolysate yield in this project, were also chosen for a scale-up. The 
enzymes selected for a scale-up for muscle and bone, based on the hydrolysate yield and the  
selectivity ratio, also showed high results in the antioxidant assay. However, the enzymes 
selected for skin based on the same criteria did not have high antioxidant results. Therefore, an 
additional enzyme (Endocut 02) was chosen, which produced the hydrolysate with high result 
in antioxidant assay and have low price per kg. Thus, larger scale experiment is intended to 
help chose one enzyme per material. 
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An overall aim is a hydrolysis process that is economically viable. Yield has high importance 
in this connection; therefore, enzymes should be tested at their optimum temperature to work 
at their optimum activity. However, pH will not be adjusted because pH adjustment with acid 
or base might result in high levels of salt in the final hydrolysate reducing the nutritional value 
of the product (Aspevik et al., 2017). The state of proteins in the raw material is influenced by 
the temperature  (Skipnes et al., 2008), which might influence the enzymes’ accessibility to the 
substrate (Slizyte et al., 2005a). Therefore, any possible reduction in yield has to be identified 
at a laboratory scale. 
For several reasons it is expected that a scale-up from 5 g to 250 g will allow a more accurate 
and detailed understanding of the process. First, a 50-fold increase in the amount of raw material 
will result in a more homogenous sample, which will make the yield less influenced by any 
small variations in each sample. Second, a more nuanced understanding of the process will be 
achieved by monitoring the hydrolysis process at different timepoints, determination of ash 
content in freeze-dried hydrolysates and determination of dry matter as well as ash content of 
the sediment (Figure 21). 
Suggested further experiments 
Additional experiments can be considered to get a better understanding of the hydrolysis 
process and further analyze the hydrolysates. It could be interesting to investigate the proteases 
used for hydrolysis and identify why Tail enzymes produced hydrolysates with higher yield 
from all three types of raw material. A characterization of proteases could be done by 
measurement of protease activity, for example using azo-casein assay. Another option is to 
determine the composition of the enzymes’ preparations by e.g. mass spectrometric analysis. 
Also, determination of collagen content in the hydrolysates could be done to identify the purity 
of the raw materials. This could be done by determination of L-hydroxyproline concentration. 
An alternative to SEC monitoring of the hydrolysis process could be a Fourier transform 
infrared (FTIR) spectroscopy. An advantage of FTIR is shorter analysis time in comparison to 
SEC, which allows for near real-time monitoring of the hydrolysis process (Vang et al., 2018). 
Protein hydrolysates are being developed for human consumption; therefore, the sensory 





The hydrolysates produced by 23 proteases from different materials of Atlantic cod heads 
(muscle, skin and bone) were evaluated and compared based on several criteria such as yield, 
selectivity towards different substrates, MW and bioactive properties. Further, based on the 
results, conditions for a scale-up experiment (from 5 g of raw material to 250 g) were proposed. 
The hydrolysate yield and the amount of sediment left after hydrolysis revealed that there were 
no clear differences among the majority of hydrolysates produced from the same type of 
material. The highest hydrolysate yield was produced by Tail enzymes from all types of 
material: from muscle by Tail 191, from skin by Tail 194, and from bone by Tail 190. As 
expected, different proteases produced hydrolysates with different average MW. However, the 
same enzyme (Tail 189) produced hydrolysates with the lowest average MW from all three 
types of raw material. Type of material also contributed to the variation in average MW; the 
average MW of hydrolysates produced from skin was higher than the average MW of 
hydrolysates from muscle and from bone. The SDS-PAGE patterns’ analysis of the 
hydrolysates from skin indicated that Tail 193 and Endocut 01 might have selectivity towards 
peptide bonds they cleave. Another observation from SDS-PAGE patterns was that Corolase 
2TS might be the most effective protease for cod skin hydrolysis out of the proteases tested. 
The selectivity of the proteases towards collagen or myofibrillar proteins were determined 
based on the yield ratio, which showed that only Flavourzyme demonstrated selectivity towards 
collagen, and that Endocut 01 had the highest selectivity towards myofibrillar proteins. The 
bioactivity assays showed that the hydrolysates did not have antiproliferative or anti-
inflammatory properties under the conditions used; however, antioxidant properties were 
observed in all hydrolysates. The suggestions for a scale-up experiment include 
recommendation of several enzymes per material based on hydrolysate yield, selectivity ratio, 
antioxidative properties and consideration of price; hydrolysis conditions (optimal temperature 
and not adjustment of pH); monitoring the progression of hydrolysis by taking test samples for 
evaluation of MW distribution and determination of the amount of protein content and ash 





Acosta-Pavas, J. C., & Ruiz-Colorado, A. A. (2020). Approximation of Scale-Up of 
Enzymatic Hydrolysis Process from Phenomenological-Based Semiphysical Model and 
Control Theory Tools. Industrial & Engineering Chemistry Research, 59, 8046–8065. 
https://doi.org/10.1021/acs.iecr.9b06912 
Adler-Nissen, J. (1993). Proteases. In T. Nagodawithana & G. Reed (Eds.), Enzymes in Food 
Processing (3rd ed., pp. 148–204). Academic Press. 
Ahmad, T. B., Rudd, D., Kotiw, M., Liu, L., & Benkendorff, K. (2019). Correlation between 
Fatty Acid Profile and Anti-Inflammatory Activity in Common Australian Seafood by-
Products. Marine Drugs, 17(155), 1–20. https://doi.org/10.3390/md17030155 
Ahn, C.-B., Cho, Y.-S., & Je, J.-Y. (2015). Purification and anti-inflammatory action of 
tripeptide from salmon pectoral fin byproduct protein hydrolysate. Food Chemistry, 168, 
151–156. https://doi.org/10.1016/j.foodchem.2014.05.112 
Ahn, C.-B., Je, J.-Y., & Cho, Y.-S. (2012). Antioxidant and anti-inflammatory peptide 
fraction from salmon byproduct protein hydrolysates by peptic hydrolysis. Food 
Research International, 49(1), 92–98. https://doi.org/10.1016/j.foodres.2012.08.002 
Ahn, C.-B., Kim, J.-G., & Je, J.-Y. (2014). Purification and antioxidant properties of 
octapeptide from salmon byproduct protein hydrolysate by gastrointestinal digestion. 
Food Chemistry, 147, 78–83. https://doi.org/10.1016/j.foodchem.2013.09.136 
Alberts, B., Johnson, A. D., Lewis, J., Morgan, D., Raff, M., Roberts, K., & Walter, P. 
(2015). Molecular Biology of the Cell (6th ed.). Garland Science. 
Alemán, A., & Martínez-Alvarez, O. (2013). Marine collagen as a source of bioactive 
molecules. A review. The Natural Products Journal, 3(2), 105–114. 
Arnesen, J. A., & Gildberg, A. (2006). Extraction of muscle proteins and gelatine from cod 
head. Process Biochemistry, 41, 697–700. https://doi.org/10.1016/j.procbio.2005.09.001 
Arnesen, J. A., & Gildberg, A. (2007). Extraction and characterisation of gelatine from 
Atlantic salmon (Salmo salar) skin. Bioresource Technology, 98(1), 53–57. 
https://doi.org/10.1016/j.biortech.2005.11.021 
Aspevik, T., Oterhals, Å., Rønning, S. B., Altintzoglou, T., Wubshet, S. G., Gildberg, A., 
Afseth, N. K., Whitaker, R. D., & Lindberg, D. (2017). Valorization of Proteins from 
Co- and By-Products from the Fish and Meat Industry. In C. S. K. Lin (Ed.), Chemistry 
and Chemical Technologies in Waste Valorization (pp. 123–150). Springer. 
https://doi.org/10.1007/978-3-319-90653-9 
Benjakul, S., Yarnpakdee, S., Senphan, T., Halldorsdottir, S. M., & Kristinsson, H. G. (2014). 
Fish protein hydrolysates: production, bioactivities, and applications. In H. G. 
Kristinsson (Ed.), Antioxidants and Functional Components in Aquatic Foods (1st ed., 
pp. 237–282). Wiley Blackwell. 
Bio-Rad Laboratories. (2017). A Guide to Polyacrylamide Gel Electrophoresis and Detection 
(pp. 1–92). 
Biosciences. (n.d.). Cytokine ELISA Protocol. Retrieved April 12, 2020, from 
https://www.bdbiosciences.com/us/applications/s/cytokineelisa 
Böcker, U., Wubshet, S. G., Lindberg, D., & Afseth, N. K. (2017). Fourier-transform infrared 
spectroscopy for characterization of protein chain reductions in enzymatic reactions. 
Analyst, 142, 2812–2818. https://doi.org/10.1039/c7an00488e 
Boster Biological Technology. (n.d.). What is ELISA? Retrieved April 12, 2020, from 
https://www.bosterbio.com/protocol-and-troubleshooting/elisa-principle 
Burton, D., & Burton, M. (2018). The integument. In D. Burton & M. Burton (Eds.), 




Cancre, I., Ravallec, R., Wormhoudt, A. Van, Stenberg, E., Gildberg, A., & Gal, Y. Le. 
(1999). Secretagogues and Growth Factors in Fish and Crustacean Protein Hydrolysates. 
Marine Biotechnology, 1(5), 489–494. 
Chalamaiah, M., Dinesh, B., Hemalatha, R., Jyothirmayi, T., Dinesh Kumar, B., Hemalatha, 
R., Jyothirmayi, T., Dinesh, B., Hemalatha, R., & Jyothirmayi, T. (2012). Fish protein 
hydrolysates: Proximate composition, amino acid composition, antioxidant activities and 
applications: A review. Food Chemistry, 135(4), 3020–3038. 
https://doi.org/10.1016/j.foodchem.2012.06.100 
Chalamaiah, Meram, Yu, W., & Wu, J. (2018). Immunomodulatory and anticancer protein 
hydrolysates (peptides) from food proteins: A review. Food Chemistry, 245, 205–222. 
https://doi.org/10.1016/j.foodchem.2017.10.087 
Chen, J., Li, L., Yi, R., Xu, N., Gao, R., & Hong, B. (2016). Extraction and characterization 
of acid-soluble collagen from scales and skin of tilapia (Oreochromis niloticus). LWT - 
Food Science and Technology, 66, 453–459. https://doi.org/10.1016/j.lwt.2015.10.070 
Chen, Y., Xie, W., Qu, C., Zheng, J., Jin, S., Li, H., Li, H., Jin, G., Meng, F., & Jin, D. 
(2019). Immunoenhancement of dried cod skin collagen: Oligo-peptides on 
cyclophosphamide-induced immunosuppression in mice. International Journal of 
Clinical and Experimental Medicine, 12(6), 7047–7055. 
Cheng, K.-K., Zhang, J.-A., Liu, D.-H., Sun, Y., Liu, H., Yang, M.-D., & Xu, J.-M. (2007). 
Pilot-scale production of 1,3-propanediol using Klebsiella pneumoniae. Process 
Biochemistry, 42, 740–744. https://doi.org/10.1016/j.procbio.2007.01.001 
Cheng, M.-L., Wang, H.-C., Hsu, K.-C., & Hwang, J.-S. (2015). Anti-inflammatory peptides 
from enzymatic hydrolysates of tuna cooking juice. Food and Agricultural Immunology, 
26(6), 770–781. https://doi.org/10.1080/09540105.2015.1036352 
Cheung, R. C. F., Ng, T. B., & Wong, J. H. (2015). Marine Peptides: Bioactivities and 
Applications. Marine Drugs, 13, 4006–4043. https://doi.org/10.3390/md13074006 
Chi, C., Wang, B., Wang, Y., & Zhang, B. (2015). Isolation and characterization of three 
antioxidant peptides from protein hydrolysate of bluefin leatherjacket (Navodon 
septentrionalis) heads. Journal of Functional Foods, 12, 1–10. 
https://doi.org/10.1016/j.jff.2014.10.027 
Cicero, A. F. G., Fogacci, F., & Colletti, A. (2017). Potential role of bioactive peptides in 
prevention and treatment of chronic diseases: a narrative review. British Journal of 
Pharmacology, 174, 1378–1394. https://doi.org/10.1111/bph.13608 
Clark, D. P., & Pazdernik, N. J. (2016). Proteomics. In D. P. Clark & N. J. Pazdernik (Eds.), 
Biotechnology (2nd ed., pp. 295–333). Elsevier Inc. https://doi.org/10.1016/B978-0-12-
385015-7.00009-0 
Cronk, D. (2013). High-throughput screening. In R. Hill & H. Rang (Eds.), Drug Discovery 
and Development: Technology in Transition (Second, pp. 95–117). Elsevier Ltd. 
https://doi.org/10.1016/B978-0-7020-4299-7.00008-1 
Crowther, J. R. (2001). The ELISA Guidebook. Humana Press. 
Cui, F. Z., Li, Y., & Ge, J. (2007). Self-assembly of mineralized collagen composites. 
Materials Science and Engineering R: Reports, 57(1–6), 1–27. 
https://doi.org/10.1016/j.mser.2007.04.001 
Dale, H. F., Jensen, C., Hausken, T., Lied, E., Hatlebakk, J. G., Brønstad, I., Lihaug Hoff, D. 
A., & Lied, G. A. (2018). Effect of a cod protein hydrolysate on postprandial glucose 
metabolism in healthy subjects: a double-blind cross-over trial. Journal of Nutritional 
Science, 7(33), 1–9. https://doi.org/10.1017/jns.2018.23 
Dragnes, B. T., Stormo, S. K., Larsen, R., Ernstsen, H. H., & Elvevoll, E. O. (2009). 
Utilisation of fish industry residuals: Screening the taurine concentration and angiotensin 
converting enzyme inhibition potential in cod and salmon. Journal of Food Composition 
 
62 
and Analysis, 22, 714–717. https://doi.org/10.1016/j.jfca.2009.01.020 
Ehly, M., Gemperline, P. J., Nordon, A., Littlejohn, D., Basford, J. K., & Cecco, M. De. 
(2007). Scale-up of batch kinetic models. Analytica Chimica Acta, 595, 80–88. 
https://doi.org/10.1016/j.aca.2007.02.040 
Elias, R. J., Kellerby, S. S., & Decker, E. A. (2008). Antioxidant Activity of Proteins and 
Peptides. Critical Reviews in Food Science and Nutrition, 48(5), 430–441. 
https://doi.org/10.1080/10408390701425615 
EU Parliament, & Council of the EU. (2009). REGULATION (EC) No 1069/2009 OF THE 
EUROPEAN PARLIAMENT AND OF THE COUNCIL (Animal by-products Regulation) 
(1069/2009; Issue October). 
FAO. (2018). The State of World Fisheries and Aquaculture 2018 - Meeting the sustainable 
development goals. http://www.fao.org/3/i9540en/i9540en.pdf 
Farvin, K. H. S., Andersen, L. L., Otte, J., Nielsen, H. H., Jessen, F., & Jacobsen, C. (2016). 
Antioxidant activity of cod (Gadus morhua) protein hydrolysates: Fractionation and 
characterisation of peptide fractions. Food Chemistry, 204, 409–419. 
https://doi.org/10.1016/j.foodchem.2016.02.145 
Farvin, K. H. S., Lystbæk, L., Hauch, H., Jacobsen, C., Jakobsen, G., Johansson, I., & Jessen, 
F. (2014). Antioxidant activity of Cod (Gadus morhua) protein hydrolysates: In vitro 
assays and evaluation in 5 % fish oil-in-water emulsion. Food Chemistry, 149, 326–334. 
https://doi.org/10.1016/j.foodchem.2013.03.075 
Fernandes, P. (2016). Enzymes in Fish and Seafood Processing. Frontiers in Bioengineering 
and Biotechnology, 4(July), 1–14. https://doi.org/10.3389/fbioe.2016.00059 
Fouchereau-Peron, M., Duvail, L., Michel, C., Gildberg, A., Batista, I., & Gal, Y. (1999). 
Isolation of an acid fraction from a fish protein hydrolysate with a calcitonin-gene-
related-peptide-like biological activity. Biotechnology and Applied Biochemistry, 29, 87–
92. 
Gildberg, A. (1993). Enzymic Processing of Marine Raw Materials. Process Biochemistry, 
28, 1–15. 
Gildberg, A., Arnesen, J. A., & Carlehog, M. (2002). Utilisation of cod backbone by 
biochemical fractionation. Process Biochemistry, 38, 475–480. 
Girgih, A. T., He, R., Hasan, F. M., Udenigwe, C. C., Gill, T. A., & Aluko, R. E. (2015). 
Evaluation of the in vitro antioxidant properties of a cod (Gadus morhua) protein 
hydrolysate and peptide fractions. Food Chemistry, 173, 652–659. 
https://doi.org/10.1016/j.foodchem.2014.10.079 
Glazer, A. N. (1988). Fluorescence-based species: assay for reactive oxygen a protective role 
for creatinine. The FASEB Journal, 2(9), 2487–2491. 
doi.org/10.1096/fasebj.2.9.3371593 
Godinho, I., Pires, C., Pedro, S., Teixeira, B., Mendes, R., Nunes, M. L., & Batista, I. (2016). 
Antioxidant Properties of Fish Protein Hydrolysates Prepared from Cod Protein 
Hydrolysate by Bacillus sp. Applied Biochemistry and Biotechnology, 178, 1095–1112. 
https://doi.org/10.1007/s12010-015-1931-5 
Gomez-Guillen, M. C., Gimenez, B., Lopez-Caballero, M. E., & Montero, M. P. (2011). 
Functional and bioactive properties of collagen and gelatin from alternative sources: A 
review. Food Hydrocolloids, 25(8), 1813–1827. 
https://doi.org/10.1016/j.foodhyd.2011.02.007 
Gordon, E., & Lorimer, J. W. (1960). The acid-soluble collagen of cod skin. Archives of 
Biochemistry and Biophysics, 88, 373–381. 
Halim, N. R. A., Azlan, A., Yusof, H. M., & Sarbon, N. M. (2018). Antioxidant and 
anticancer activities of enzymatic eel (monopterus sp) protein hydrolysate as influenced 




Halim, N. R. A., Yusof, H. M., & Sarbon, N. M. (2016). Functional and bioactive properties 
of fish protein hydolysates and peptides: A comprehensive review. Trends in Food 
Science and Technology, 51, 24–33. https://doi.org/10.1016/j.tifs.2016.02.007 
Hall, G. M. (2011). Surimi and Fish Mince Products. In G. M. Hall (Ed.), Fish Processing – 
Sustainability and New Opportunities (pp. 98–111). Wiley Blackwell. 
Halldorsdottir, S. M., Sveinsdottir, H., Freysdottir, J., & Kristinsson, H. G. (2014). Oxidative 
processes during enzymatic hydrolysis of cod protein and their influence on antioxidant 
and immunomodulating ability. Food Chemistry, 142, 201–209. 
https://doi.org/10.1016/j.foodchem.2013.07.053 
Hardin, J., Bertoni, G., & Kleinsmith, L. J. (2016). Becker’s World of the Cell. Technology 
Update (8th Editio). Pearson. 
Harnedy, A., & Fitzgerald, R. J. (2012). Bioactive peptides from marine processing waste and 
shellfish: A review. Journal of Functional Foods, 4, 6–24. 
https://doi.org/10.1016/j.jff.2011.09.001 
Hawkes, J. W. (1974). The structure of fish skin. Cell and Tissue Research, 149(712), 147–
158. https://doi.org/10.1007/BF00222271 
Hayes, M., & McKeon, K. (2014). Advances in the Processing of Marine Discard and By-
products. In S. K. Kim (Ed.), Seafood Processing By-Products. Trends and Applications 
(pp. 125–144). Springer. 
He, S., Franco, C., & Zhang, W. (2013). Functions, applications and production of protein 
hydrolysates from fish processing co-products (FPCP). Food Research International, 50, 
289–297. https://doi.org/10.1016/j.foodres.2012.10.031 
Heo, S.-Y., Ko, S.-C., Nam, S. Y., Oh, J., Kim, Y.-M., Kim, J.-I., Namwon, K., Myunggi, Y., 
& Jung, W.-K. (2018). Fish bone peptide promotes osteogenic differentiation of MC3T3‐
E1 pre‐osteoblasts through upregulation of MAPKs and Smad pathways activated BMP‐
2 receptor. Cell Biochemistry & Function, 36, 137–146. https://doi.org/10.1002/cbf.3325 
Himonides, A. T., Taylor, A. K. D., & Morris, A. J. (2011). Enzymatic Hydrolysis of Fish 
Frames Using Pilot Plant Scale Systems. Food and Nutrition Sciences, 2, 586–593. 
https://doi.org/10.4236/fns.2011.26082 
Hooper, N. M. (2002). Proteases: a primer. Biochemical Society, 38, 1–8. 
https://doi.org/10.1042/bse0380001 
Hsu, K.-C., Li-Chan, E. C. Y., & Jao, C.-L. (2011). Antiproliferative activity of peptides 
prepared from enzymatic hydrolysates of tuna dark muscle on human breast cancer cell 
line MCF-7. Food Chemistry, 126, 617–622. 
https://doi.org/10.1016/j.foodchem.2010.11.066 
Huang, D., Ou, B., Hampsch-Woodill, M., Flanagan, J. A., & Prior, R. L. (2002). High-
Throughput Assay of Oxygen Radical Absorbance Capacity (ORAC) Using a 
Multichannel Liquid Handling System Coupled with a Microplate Fluorescence Reader 
in 96-Well Format. Journal of Agricultural and Food Chemistry, 50, 4437–4444. 
https://doi.org/10.1021/jf0201529 
Invitrogen. (2016). Protein gel electrophoresis technical handbook (pp. 1–87). ThermoFisher 
Scientific. 
Ishak, N. H., & Sarbon, N. M. (2018). A Review of Protein Hydrolysates and Bioactive 
Peptides Deriving from Wastes Generated by Fish Processing. Food and Bioprocess 
Technology, 11, 2–16. https://doi.org/10.1007/s11947-017-1940-1 
Ismail, B., Mohammed, H., & Nair, A. J. (2019). Influence of Proteases on Functional 
Properties of Food. In Green Bio-processes (pp. 31–53). https://doi.org/10.1007/978-
981-13-2354-6 
Jamnik, P., Istenič, K., Koštomaj, T., Wulff, T., Geirsdóttir, M., Almgren, A., Jónsdóttir, R., 
 
64 
Kristinsson, H. G., & Undeland, I. (2017). Bioactivity of Cod and Chicken Protein 
Hydrolysates before and after in vitro Gastrointestinal Digestion. Food Technology and 
Biotechnology, 55(3), 360–367. 
Jang, H. L., Liceaga, A. M., & Yoon, K. Y. (2017). Isolation and Characteristics of Anti-
Inflammatory Peptides from Enzymatic Hydrolysates of Sandfish (Arctoscopus 
japonicus) Protein. Journal of Aquatic Food Product Technology, 26(2), 234–244. 
https://doi.org/10.1080/10498850.2016.1221015 
Jensen, I.-J., Larsen, R., Rustad, T., & Eilertsen, K.-E. (2013). Nutritional content and 
bioactive properties of wild and farmed cod (Gadus morhua L.) subjected to food 
preparation. Journal of Food Composition and Analysis, 31, 212–216. 
https://doi.org/10.1016/j.jfca.2013.05.013 
Jensen, I., & Mæhre, H. K. (2016). Preclinical and Clinical Studies on Antioxidative, 
Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides — A 
Review. Marine Drugs, 14(211). https://doi.org/10.3390/md14110211 
Jeon, Y.-J., Byun, H.-G., & Kim, S.-K. (1999). Improvement of functional properties of cod 
frame protein hydrolysates using ultrafiltration membranes. Process Biochemistry, 35, 
471–478. 
Johansen, S. D., Coucheron, D. H., Andreassen, M., Karlsen, O., Breines, R., Furmanek, T., 
Jørgensen, T. E., Nordeide, J. T., Moum, T., Nederbragt, A. J., Stenseth, N. C., & 
Jakobsen, K. S. (2009). Large-scale sequence analyses of Atlantic cod. New 
Biotechnology, 25(5). https://doi.org/10.1016/j.nbt.2009.03.014 
Joshi, I., Sudhakar, S., & Nazeer, R. A. (2016). Anti-inflammatory Properties of Bioactive 
Peptide Derived from Gastropod Influenced by Enzymatic Hydrolysis. Applied 
Biochemistry and Biotechnology, 180, 1128–1140. https://doi.org/10.1007/s12010-016-
2156-y 
Kim, S., & Jung, W. (1996). Fish and bone as a calcium source. In Maximising the value of 
marine by-products (pp. 328–339). Woodhead Publishing Limited. 
https://doi.org/10.1016/B978-1-84569-013-7.50015-6 
Kim, S. K., & Mendis, E. (2006). Bioactive compounds from marine processing byproducts - 
A review. Food Research International, 39(4), 383–393. 
https://doi.org/10.1016/j.foodres.2005.10.010 
Kim, S. K., & Wijesekara, I. (2010). Development and biological activities of marine-derived 
bioactive peptides: A review. Journal of Functional Foods, 2(1), 1–9. 
https://doi.org/10.1016/j.jff.2010.01.003 
King, M. (2007). Fisheries Biology, Assessment and Management (2nd ed.). Blackwell 
Publishing Ltd. 
Kisitu, J., Bennekou, S. H., & Leist, M. (2019). Chemical concentrations in cell culture 
compartments (C5) – Concentration definitions. ALTEX. Alternatives to Animal 
Experimentation, 36(1), 154–160. https://doi.org/10.14573/altex.1901031 
Korczek, K., Tkaczewska, J., & Migdał, W. (2018). Antioxidant and Antihypertensive Protein 
Hydrolysates in Fish Products – a Review. Czech Journal of Food Sciences, 36(3), 195–
207. 
Kristinsson, H. G., & Rasco, B. A. (2000). Fish Protein Hydrolysates: Production, 
Biochemical, and Functional Properties. Critical Reviews in Food Science and Nutrition, 
40(1), 43–81. https://doi.org/10.1080/10408690091189266 
Kumar, N. S. S., Kumar, N. S. V., & Jaiganesh, R. (2012). Therapeutic Drugs: Healing Power 
of Marine Fish. In S.-K. Kim (Ed.), Marine Medicinal Foods. Implications and 
Applications: Animals and Microbes (pp. 269–286). Elsevier Science & Technology. 
https://doi.org/10.1016/B978-0-12-416003-3.00018-4 
Li, Z.-R., Wang, B., Chi, C., Zhang, Q.-H., Gong, Y., Tang, J.-J., Luo, H., & Ding, G. (2013). 
 
65 
Isolation and characterization of acid soluble collagens and pepsin soluble collagens 
from the skin and bone of Spanish mackerel (Scomberomorous niphonius). Food 
Hydrocolloids, 31(1), 103–113. https://doi.org/10.1016/j.foodhyd.2012.10.001 
Liu, D., Liang, L., Regenstein, J. M., & Zhou, P. (2012). Extraction and characterisation of 
pepsin-solubilised collagen from fins, scales, skins, bones and swim bladders of bighead 
carp (Hypophthalmichthys nobilis). Food Chemistry, 133(4), 1441–1448. 
https://doi.org/10.1016/j.foodchem.2012.02.032 
Liu, D., Nikoo, M., Boran, G., Zhou, P., & Regenstein, J. M. (2015). Collagen and Gelatin. 
Annual Review of Food Science and Technology, 6(1), 527–557. 
https://doi.org/10.1146/annurev-food-031414-111800 
Lordan, S., Ross, R. P., & Stanton, C. (2011). Marine bioactives as functional food 
ingredients: Potential to reduce the incidence of chronic diseases. Marine Drugs, 9, 
1056–1100. https://doi.org/10.3390/md9061056 
Malawer, E. G., & Senak, L. (2004). Introduction to Size Exclusion Chromatography. In C.-S. 
Wu (Ed.), Handbook of Size Exclusion Chromatography (2nd ed., pp. 1–24). Marcek 
Dekker. 
Meinlschmidt, P., Sussmann, D., Schweiggert-Weisz, U., & Eisner, P. (2016). Enzymatic 
treatment of soy protein isolates: effects on the potential allergenicity, 
technofunctionality, and sensory properties. Food Science and Nutrition, 4(1), 11–23. 
https://doi.org/10.1002/fsn3.253 
Merz, M., Claaßen, W., Appel, D., Berends, P., Rabe, S., Blank, I., Stressler, T., & Fischer, L. 
(2016). Enzymatic Characterization of commercially available peptidases in respect of 
the production of protein hydrolysates with defined compositions using a three-step 
methodology. Journal of Molecular Catalysis B: Enzymatic, 127, 1–10. 
https://doi.org/10.1016/j.molcatb.2016.02.002 
Moen, F. E., & Svensen, E. (2004). Marine fish and invertebrates of Northen Europe. KOM. 
Mori, S., & Barth, H. G. (1999). Size exclusion chromatography. Springer. 
Muralidharan, N., Shakila, R. J., Sukumar, D., & Jeyasekaran, G. (2013). Skin, bone and 
muscle collagen extraction from the trash fish, leather jacket (Odonus niger) and their 
characterization. Journal of Food Science and Technology, 50(6), 1106–1113. 
https://doi.org/10.1007/s13197-011-0440-y 
Naqash, S. Y., & Nazeer, R. A. (2010). Antioxidant Activity of Hydrolysates and Peptide 
Fractions of Nemipterus japonicus and Exocoetus volitans Muscle. Journal of Aquatic 
Food Product Technology, 19(3–4), 180–192. 
https://doi.org/10.1080/10498850.2010.506256 
Nasri, M. (2017). Protein Hydrolysates and Biopeptides: Production , Biological Activities , 
and Applications in Foods and Health Benefits. A Review. In F. Toldrá (Ed.), Advances 
in Food and Nutrition Research (pp. 109–159). Elsevier Science & Technology. 
Nelson, D. L., & Cox, M. M. (2013). Principles of Biochemistry. Lehninger (6th ed.). W. H. 
Freeman and Company. 
Neubauer, P., Cruz, N., Glauche, F., Junne, S., Knepper, A., & Raven, M. (2013). Consistent 
development of bioprocesses from microliter cultures to the industrial scale. Engineering 
in Life Sciences, 13, 224–238. https://doi.org/10.1002/elsc.201200021 
Ngo, D.-H., Vo, T.-S., Ngo, D.-N., Wijesekara, I., & Kim, S.-K. (2012). Biological activities 
and potential health benefits of bioactive peptides derived from marine organisms. 
International Journal of Biological Macromolecules, 51(4), 378–383. 
https://doi.org/10.1016/j.ijbiomac.2012.06.001 
Nofima. (2018). Cod heads and chicken carcasses rise in value. 
https://nofima.no/en/nyhet/2018/12/cod-heads-and-chicken-carcasses-rise-in-value/ 
Novozymes A/S. (2017). Product Data Sheet: Flavourzyme 1000 L (pp. 1–2). 
 
66 
Nwachukwu, I. D., & Aluko, R. E. (2019). Anticancer and antiproliferative properties of 
food-derived protein hydrolysates and peptides. Journal of Food Bioactives, 7, 18–26. 
https://doi.org/10.31665/JFB.2019.7194 
Ou, B., Hampsch-Woodill, M., & Prior, R. L. (2001). Development and Validation of an 
Improved Oxygen Radical Absorbance Capacity Assay Using Fluorescein as the 
Fluorescent Probe. Journal of Agricultural and Food Chemistry, 49, 4619–4626. 
https://doi.org/10.1021/jf010586o 
Pal, G. K., & Suresh, P. V. (2017). Comparative assessment of physico-chemical 
characteristics and fibril formation capacity of thermostable carp scales collagen. 
Materials Science and Engineering C, 70, 32–40. 
https://doi.org/10.1016/j.msec.2016.08.047 
Pal, G. K., & Suresh, P. V. (2016). Sustainable valorisation of seafood by-products: Recovery 
of collagen and development of collagen-based novel functional food ingredients. 
Innovative Food Science and Emerging Technologies, 37, 201–215. 
https://doi.org/10.1016/j.ifset.2016.03.015 
Pampanin, D. M., Haarr, M. B., & Sydnes, M. O. (2016). Natural peptides with antioxidant 
activity from Atlantic cod and Atlantic salmon residual material. International Journal 
of Applied Research in Natural Products, 9(2), 1–8. 
Pan, X., Zhao, Y.-Q., Hu, F.-Y., Chi, C.-F., & Wang, B. (2016). Anticancer Activity of a 
Hexapeptide from Skate (Raja porosa) Cartilage Protein Hydrolysate in HeLa Cells. 
Marine Drugs, 1–11. https://doi.org/10.3390/md14080153 
Parkin, K. L. (1993a). Environmental Effects on Enzyme Activity. In T. Nagodawithana & G. 
Reed (Eds.), Enzymes in Food Processing (3rd ed., pp. 39–70). Academic Press. 
Parkin, K. L. (1993b). General Characteristics of Enzymes. In T. Nagodawithana & G. Reed 
(Eds.), Enzymes in Food Processing (3rd ed., pp. 7–38). Academic Press. 
Petsko, G. A., & Ringe, D. (2009). Protein Structure and Function. Oxford University Press. 
Piccinno, F., Hischier, R., Seeger, S., & Som, C. (2016). From laboratory to industrial scale: a 
scale-up framework for chemical processes in life cycle assessment studies. Journal of 
Cleaner Production, 135, 1085–1097. https://doi.org/10.1016/j.jclepro.2016.06.164 
Picot, L., Bordenave, S., Didelot, S., Fruitier-Arnaudin, I., Sannier, F., Thorkelsson, G., 
Berge, J. P., Guerard, F., Chabeaud, A., & Piot, J. M. (2006). Antiproliferative activity 
of fish protein hydrolysates on human breast cancer cell lines. Process Biochemistry, 41, 
1217–1222. https://doi.org/10.1016/j.procbio.2005.11.024 
Podzimek, S. (2010). Size Exclusion Chromatography. In S. Podzimek (Ed.), Light 
Scattering, Size Exclusion Chromatography and Asymmetric Flow Field Flow 
Fractionation. Wiley. 
Promega. (2012). CellTiter 96® AQueous One Solution Cell Proliferation Assay (pp. 2014-
12–15). www.promega.com/protocols/ 
Richardsen, R., Myhre, M., Nystøyl, R., Strandheim, G., & Marthinussen, A. (2019). Analyse 
marint restråstoff 2018 (pp. 1–35). 
Riss, T. L., Moravec, R. A., Niles, A. L., Benink, H. A., & Worzella, T. J. (2016). Cell 
Viability Assays. In G. S. Sittampalam (Ed.), Assay Guidance Manual (pp. 1–31). Eli 
Lilly & Company and the National Center for Advancing Translational Sciences. 
Rocha, M. Da, Alemán, A., Baccan, G. C., Elvira, M., Gómez-guillén, C., Montero, P., & 
Prentice, C. (2018). Anti-Inflammatory, Antioxidant, and Antimicrobial Effects of 
Underutilized Fish Protein Hydrolysate. Journal of Aquatic Food Product Technology, 
27(5), 592–608. https://doi.org/10.1080/10498850.2018.1461160 
Rustad, T. (2006). Physical and chemical properties of protein seafood by-products. In F. 




Rustad, T., & Hayes, M. (2012). Marine Bioactive Peptides and Protein Hydrolysates: 
Generation, Isolation Procedures, and Biological and Chemical Characterizations. In M. 
Hayes (Ed.), Marine Bioactive Compounds: Sources, Characterization and Applications 
(pp. 99–114). Springer. 
Rustad, T., Storrø, I., & Slizyte, R. (2011). Possibilities for the utilisation of marine by-
products. International Journal of Food Science and Technology, 46(10), 2001–2014. 
https://doi.org/10.1111/j.1365-2621.2011.02736.x 
Sable, R., Parajuli, P., & Jois, S. (2017). Peptides, peptidomimetics, and polypeptides from 
marine sources: A wealth of natural sources for pharmaceutical applications. Marine 
Drugs, 15(4). https://doi.org/10.3390/md15040124 
Sarmadi, B. H., & Ismail, A. (2010). Antioxidative peptides from food proteins: A review. 
Peptides, 31, 1949–1956. https://doi.org/10.1016/j.peptides.2010.06.020 
Shahidi, F., Naczk, M., Pegg, R. B., & Synowiecki, J. (1991). Chemical Composition and 
Nutritional Value of Processing Discards of Cod (Gadus morhua). Food Chemistry, 42, 
145–151. 
Shinnar, R. (2004). A Systematic Methodology for the Design Development and Scale-up of 
Complex Chemical Processes . The Role of Control and Concurrent Design. Industrial & 
Engineering Chemistry Research, 43, 246–269. https://doi.org/10.1021/ie0304715 
Sila, A., & Bougatef, A. (2016). Antioxidant peptides from marine by-products: Isolation, 
identification and application in food systems. A review. Journal of Functional Foods, 
21, 10–26. https://doi.org/10.1016/j.jff.2015.11.007 
Skierka, E., & Sadowska, M. (2007). The influence of different acids and pepsin on the 
extractability of collagen from the skin of Baltic cod (Gadus morhua). Food Chemistry, 
105, 1302–1306. https://doi.org/10.1016/j.foodchem.2007.04.030 
Skipnes, D., Plancken, I. Van Der, Loey, A. Van, & Hendrickx, M. E. (2008). Kinetics of heat 
denaturation of proteins from farmed Atlantic cod (Gadus morhua). Journal of Food 
Engineering, 85, 51–58. https://doi.org/10.1016/j.jfoodeng.2007.06.030 
Slizyte, R., Dauksas, E., Falch, E., Storrø, I., & Rustad, T. (2005a). Characteristics of protein 
fractions generated from hydrolysed cod (Gadus morhua) by-products. Process 
Biochemistry, 40, 2021–2033. https://doi.org/10.1016/j.procbio.2004.07.016 
Slizyte, R., Dauksas, E., Falch, E., Storrø, I., & Rustad, T. (2005b). Yield and composition of 
different fractions obtained after enzymatic hydrolysis of cod (Gadus morhua) by-
products. Process Biochemistry, 40, 1415–1424. 
https://doi.org/10.1016/j.procbio.2004.06.033 
Slizyte, R., Mozuraityte, R., Martínez-Alvarez, O., Falch, E., Fouchereau-Peron, M., Rustad, 
T., Martinez-Alvarez, O., Falch, E., Fouchereau-Peron, M., & Rustad, T. (2009). 
Functional, bioactive and antioxidative properties of hydrolysates obtained from cod 
(Gadus morhua) backbones. Process Biochemistry, 44, 668–677. 
https://doi.org/10.1016/j.procbio.2009.02.010 
Song, R., Wei, R., Luo, H., & Yang, Z. (2014). Isolation and identification of an 
antiproliferative peptide derived from heated products of peptic hydrolysates of half-fin 
anchovy (Setipinna taty). Journal of Functional Foods, 10, 104–111. 
https://doi.org/10.1016/j.jff.2014.06.010 
Song, R., Wei, R., Zhang, B., Yang, Z., & Wang, D. (2011). Antioxidant and 
Antiproliferative Activities of Heated Sterilized Pepsin Hydrolysate Derived from Half-
Fin Anchovy (Setipinna taty). Marine Drugs, 9, 1142–1156. 
https://doi.org/10.3390/md9061142 
Statistics Norway. (2020). Fisheries. https://www.ssb.no/en/jord-skog-jakt-og-
fiskeri/statistikker/fiskeri 
Stock, S. R. (2015). The Mineral–Collagen Interface in Bone. Calcified Tissue International, 
 
68 
97(3), 262–280. https://doi.org/10.1007/s00223-015-9984-6.The 
Striegel, A. M., Yau, W. W., Kirkland, J. J., & Bly, D. D. (2009). Modern Size-Exclusion 
Liquid Chromatography (2nd ed.). Wiley. 
Suarez-Jimenez, G.-M., Burgos-Hernandez, A., & Ezquerra-Brauer, J.-M. (2012). Bioactive 
Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals. 
Marine Drugs, 10, 963–986. https://doi.org/10.3390/md10050963 
Subhan, F., Kang, H. Y., Lim, Y., Ikram, M., Baek, S.-Y., Jin, S., Jeong, Y. H., Kwak, J. Y., 
& Yoon, S. (2017). Fish Scale Collagen Peptides Protect against CoCl2/TNF- α-Induced 
Cytotoxicity and Inflammation via Inhibition of ROS , MAPK , and NF- κB Pathways in 
HaCaT Cells. Oxidative Medicine and Cellular Longevity, 1–17. 
Sveinsdottir, H., Hamaguchi, P. Y., Bakken, H. E., & Kristinsson, H. G. (2014). Methods for 
assessing the antioxidative activity of aquatic food compounds. In H. G. Kristinsson 
(Ed.), Antioxidants and Functional Components in Aquatic Foods (pp. 151–174). Wiley 
Blackwell. 
Tahergorabi, R., Hosseini, S. V, & Jaczynski, J. (2011). Seafood proteins. In G. O. Phillips & 
P. A. Williams (Eds.), Handbook of Food Proteins (pp. 116–149). Woodhead 
Publishing. 
Tailorzyme. (2016). Product Data Sheet: TailorFood Endocut-01L. 
Toppe, J., Albrektsen, S., Hope, B., & Aksnes, A. (2007). Chemical composition, mineral 
content and amino acid and lipid profiles in bones from various fish species. 
Comparative Biochemistry and Physiology Part B, 146, 395–401. 
https://doi.org/10.1016/j.cbpb.2006.11.020 
Vang, B., Altintzoglou, T., Måge, I., Wubshet, S. G., Afseth, N. K., & Whitaker, R. D. 
(2018). Nofima: Peptide Recovery and Commercialization by Marine Biomass. In G. de 
Gonzalo & P. D. de María (Eds.), Biocatalysis: An Industrial Perspective (pp. 459–476). 
Royal Society of Chemistry. 
Vidanarachchi, J. K., Ranadheera, C. S., Wijerathne, T. D., Udayangani, R. M. C., Himali, S. 
M. C., & Pickova, J. (2014). Applications of Seafood By-products in the Food Industry 
and Human Nutrition. In S. Kim (Ed.), Seafood Processing By-Products. Trends and 
Applications (pp. 463–528). 
Walsh, G. (2014a). Industrial enzymes: an introduction. In Proteins: Biochemistry and 
Biotechnology (2nd ed., pp. 311–326). John Wiley & Sons, Ltd. 
Walsh, G. (2014b). Industrial enzymes: proteases and carbrohydrases. In Proteins: 
Biochemistry and Biotechnology (2nd ed., pp. 327–369). John Wiley & Sons, Ltd. 
Walsh, G. (2014c). Proteins and proteomics. In Proteins: Biochemistry and Biotechnology 
(2nd ed., pp. 1–22). Blackwell Publishing Ltd. 
Ward, O. P. (2011). Proteases. In M. Moo-Young (Ed.), Comprehensive Biotechnology (2nd 
ed., pp. 571–582). Elsevier. https://doi.org/10.1016/B978-0-08-088504-9.00222-1 
WHO. (2018). Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer 
WHO, & FAO. (2003). Diet, Nutrition and the Prevention of Chronic Diseases. 
http://www.fao.org/3/AC911E/ac911e00.htm 
Willey, J. M., Sherwood, L. M., & Woolverton, C. J. (2014). Prescott’s Micobiology (9th 
ed.). Mc Graw Hill Education. 
Wolfe, K. L., & Rui, H. L. (2007). Cellular antioxidant activity (CAA) assay for assessing 
antioxidants, foods, and dietary supplements. Journal of Agricultural and Food 
Chemistry, 55(22), 8896–8907. https://doi.org/10.1021/jf0715166 
Woo, J.-W., Yu, S.-J., Cho, S.-M., Lee, Y.-B., & Kim, S.-B. (2008). Extraction optimization 
and properties of collagen from yellowfin tuna (Thunnus albacares) dorsal skin. Food 
Hydrocolloids, 22(5), 879–887. https://doi.org/10.1016/j.foodhyd.2007.04.015 
Wubshet, S. G., Måge, I., Bocker, U., Lindberg, D., Knutsen, S. H., Rieder, A., Rodriguez, D. 
 
69 
A., & Afseth, N. K. (2017). Analytical Methods FTIR as a rapid tool for monitoring 
molecular weight distribution during enzymatic protein hydrolysis of food processing 
by-products. Analytical Methods, 9, 4247–4254. https://doi.org/10.1039/c7ay00865a 
Wubshet, S. G., Wold, J. P., Afseth, N. K., Böcker, U., Lindberg, D., Ihunegbo, F. N., & 
Måge, I. (2018). Feed-Forward Prediction of Product Qualities in Enzymatic Protein 
Hydrolysis of Poultry By-products : a Spectroscopic Approach. Food and Bioprocess 
Technology, 11, 2032–2043. https://doi.org/10.1007/s11947-018-2161-y 
Yaghoubzadeh, Z., Peyravii, F., Hami, G., Reza, K., & Esmail, S. (2020). Antioxidant 
Activity and Anticancer Effect of Bioactive Peptides from Rainbow Trout 
(Oncorhynchus mykiss) Skin Hydrolysate. International Journal of Peptide Research 
and Therapeutics, 26, 625–632. https://doi.org/10.1007/s10989-019-09869-5 
Yu, F., Zong, C., Jin, S., Zheng, J., Chen, N., Huang, J., Chen, Y., Huang, F., Yang, Z., Tang, 
Y., & Ding, G. (2018). Optimization of extraction conditions and characterization of 
pepsin-solubilised collagen from skin of giant croaker (Nibea japonica). Marine Drugs, 






A 1 List of chemicals 
Table 6 – List of chemicals used in the project. 
Type of chemical Product ID Manufacturer 
Acetonitrile  Merck, Darmstadt, Germany 
Trifluoroacetic acid  Merck, Darmstadt, Germany 
Human melanoma A2058 ATCC CRL-11147 LGC Standards, Teddington, UK 
CellTiter 96® AQueous One Solution Reagent G3581 Promega Biotech AB, Madison, 
WI, USA 
DMSO (Dimethyl sulfoxide) D4540 Sigma-Aldrich, St. Louis, USA 
Trypan Blue 0.4 % T8154 Sigma-Aldrich, St. Louis, USA 
Trypsin X0930 Biowest, Nuaillé, France 
Dulbecco’s Modified Eagle’s Medium (DMEM) D6171 Sigma-Aldrich, St. Louis, USA 
L-alanyl-L-Glutamine K0302 Biochrom Ltd., Cambridge, UK 
Fetal Bovine Serum (FBS) S1810-500 Biowest, Nuaillé, France 
Gentamycin A2712 Biochrom Ltd., Cambridge, UK 
di-Sodium hydrogen phosphate dihydrate 
(Na2HPO4 × 2H2O) 
 
Merck, Darmstadt, Germany 
2,2′-Azobis (2-methylpropionamidine) 
dihydrochloride (AAPH) 
44091-4 Sigma Aldrich, St. Louis, MO, 
USA 
Fluorescein 46960 Sigma Aldrich, St. Louis, MO, 
USA 
Trolox 238813 Sigma Aldrich, St. Louis, MO, 
USA 
THP-1 Human monocyte ATCC TIB-202 LGC Standards, Teddington, UK 
RPMI 1640, low endotoxin FG1385 Biochrom Ltd., Cambridge, UK 
Fetal Bovine Serum (FBS), Ultralow 
endotoxin 
S1860-500 Biowest, Nuaillé, France 
Phosphate Buffered Saline (PBS) D8537 Sigma-Aldrich, St. Louis, USA 
Trypan blue 0.4% 
 
Sigma-Aldrich, St. Louis, USA 
PMA, stock solution 1mg/mL P1585 Sigma-Aldrich, St. Louis, USA 
LPS L2630 Sigma-Aldrich, St. Louis, USA 
TRIZMA base 93352 Sigma-Aldrich, St. Louis, USA 
NaCl  S5886 Sigma-Aldrich, St. Louis, USA 
Tween20 P1379 Sigma-Aldrich, St. Louis, USA 
BSA A2153 Sigma-Aldrich, St. Louis, USA 
pNPP substrate 5mg S0942 Sigma-Aldrich, St. Louis, USA 
pNPP substrate 40mg P5994  Sigma-Aldrich, St. Louis, USA 
Diethanolamine D8885 Sigma-Aldrich, St. Louis, USA 
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Extravidin-alkaline phosphate E2636 Sigma-Aldrich, St. Louis, USA 
Anti-Human TNF alpha Purified  14-7348-85 eBioscience, San Diego, CA, 
United States 
Anti-Human TNF alpha Biotin 13-7349-85 eBioscience, San Diego, CA, 
United States 
Human TNF alpha recombinant protein 14-8329-63 eBioscience, San Diego, CA, 
United States 
 
Table 7 – Chemical composition of solutions used in ELISA. 
Solutions Chemicals 
10 × TBS pH 7.4 TRIZMA base 12.1 g 
NaCl 88 g 
MilliQ water 1 L 
HCl for pH adjustment to 7.4 
1 M diethanolamine buffer pH 9.8 MgCl2 100 mg 
Diethanolamine 97 mL 
MilliQ water 1 L 
HCl for pH adjustment to 9.8 
Washing buffer 1× TBS (10 mM) pH 7.4 
0.05% Tween 20 
Blocking buffer 1× TBS (10 mM) pH 7.4 
2% BSA 
Assay diluent 1× TBS (10 mM) pH 7.4 with 1% BSA 
pNPP substrate solution pNPP substrate 20mg/mL   





A 2 Calculations 
A 2.1. Adjustment of weight to 5 g for comparison 
Hydrolysis was performed in duplicate. Raw material weigh was ca. 5 g. Adjustments of 
results to 5 g were done to compare treatments with different enzymes.  
Table 8 – Weight of raw material and sediment. Example with skin as raw material and Bromelain. 
Replicate Weight of the 
raw material (g) 
Average weight of the raw 
material (g) 




 = 5.0088 
0.1386 0.14465 
II 5.0052 0.1507 
Calculation of how much sediment/freeze-dried hydrolysate is produced from 5 g of raw 
material (x): 








𝑦 =  
5 𝑔 ×100 %
5.0088 𝑔
 = 99.82 % 







𝑥 =  
99.82 % × 0.14465 𝑔
100 %
 ≈ 0.1444 g 
A 2.2.  Calculation of hydrolysate yield  
Example for muscle and Alcalase 
1) control treatment yield (muscle) = (
0.127 𝑔
0.844 𝑔
) × 100% = 15.11% 
2) total yield (muscle, Alcalase) = (
0.371𝑔
0.844𝑔
) × 100% = 43.99% 
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3) hydrolysate yield (muscle, Alcalase) = 43.99% - 15.11% = 28.88% 
A 2.3. Sediment reduction due to enzymatic hydrolysis  
Example for muscle and Alcalase 
1) control treatment sediment (muscle) = (
0.733𝑔
0.844𝑔
) × 100% = 86.86% 
2) total sediment (muscle, Alcalase) = (
0.436𝑔
0.844𝑔
) × 100% = 51.67% 
3) sediment reduction (muscle, Alcalase) = 86.86% - 51.67% = 35.19% 
A 2.4. Calculation of selectivity ratio 
Example for skin/muscle ratio and Alcalase 
Selectivity ratio (Alcalase) = 
𝐻𝑦𝑑𝑟𝑜𝑙𝑦𝑠𝑎𝑡𝑒 𝑦𝑖𝑒𝑙𝑑 𝑠𝑘𝑖𝑛 (%)




 = 0.68 
A 2.5. Weight average MW 
First, total mass of each type of molecule is calculated using the formula NiMi, where Ni is the 
number of molecules of weight Mi 
Then, the total molecular weight of the sample is calculated using the formula: ∑NiMi 
Afterwards, the weight fraction of each type of molecule (Wi) is calculated using the formula: 
Wi = NiMi/ ∑NiMi 
Weight average molecular weight  is calculated using the formula below 
Weight average MW =  ∑WiMi = 490 805.8 
Table 9 – Calculation of weight average MW. 
Number of 
molecules (Ni) 
Mass of each 
molecule (Mi) 
Total mass of each 
type of molecule 
(NiMi) 
Weight fraction 
type of molecule 
(Wi) 
WiMi 
2 800 000 1 600 000 0.11 84 544.25 
5 650 000 3 250 000 0.21 139 531 
20 420 000 8 400 000 0.55 233 025.1 




A 2.6. ORAC 
Dilution series of Trolox was used to plot a standard curve to which measured values were 
related to. First, data was normalized to the well Trolox 0 µM (phosphate buffer, fluorescein 
and AAPH):  
Areal in between curves = Areal under curvesample – Areal under curveTrolox 0 
The equation for trend line was made based on the normalized data. Trolox equivalent (µM) 
was calculated using this equation: 
y = ax + b, => x = (y – b)/a,  
where y is Areal under curvesample  
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A 3 Hydrolysis 
Table 10 – Hydrolysis results from muscle: weight of freeze-dried hydrolysate (adjusted per 5 g for comparison) with standard deviation, percentage of total yield (relative to the 
dry weight of the material) and hydrolysate yield; weight of sediment (adjusted per 5 g for comparison) with standard deviation, percentage of sediment (relative to the dry weight 
















to dry matter (%) 
Sediment reduction 
due to enzymatic 
hydrolysis (%) 
Alcalase 0.37 0.003 44.0 28.9 0.44 0.004 51.7 35.2 
Bromelain 0.33 0.011 38.9 23.8 0.51 0.022 60.8 26.0 
Corolase 2TS 0.46 0.020 54.2 39.1 0.36 0.038 43.0 43.8 
Corolase 7090 0.41 0.008 48.3 33.2 0.40 0.005 47.0 39.8 
Tail 10 0.42 0.001 49.7 34.5 0.49 0.002 57.8 29.1 
Tail 189 0.53 0.012 62.7 47.6 0.44 0.002 52.1 34.8 
Tail 190 0.38 0.014 45.3 30.2 0.51 0.016 60.4 26.4 
Tail 191 0.55 0.004 65.1 50.0 0.34 0.003 40.5 46.4 
Tail 192 0.43 0.005 50.6 35.5 0.50 0.005 59.6 27.2 
Tail 193 0.45 0.010 52.9 37.8 0.49 0.015 57.8 29.0 
Tail 194 0.54 0.014 63.7 48.6 0.40 0.010 47.1 39.7 
Tail 197 0.45 0.003 52.8 37.7 0.45 0.004 52.8 34.1 
FoodPro 30L 0.39 0.016 46.7 31.6 0.51 0.016 60.6 26.3 
FoodPro 51FP 0.42 0.023 49.4 34.3 0.49 0.004 57.6 29.3 
FoodPro PNL 0.44 0.019 52.2 37.1 0.44 0.016 51.9 35.0 
Veron L10 0.31 0.004 36.8 21.7 0.56 0.003 66.8 20.0 
Flavourzyme 0.30 0.013 35.4 20.3 0.57 0.017 67.0 19.9 
Protamex 0.43 0.013 50.7 35.6 0.44 0.012 51.8 35.1 
Promod 144GL 0.33 0.002 39.3 24.2 0.52 0.015 62.0 24.9 
Promod P950L 0.41 0.002 48.0 32.9 0.43 0.008 50.5 36.4 
Endocut 01 0.35 0.007 41.3 26.2 0.54 0.001 63.6 23.2 
Endocut 02 0.45 0.002 53.3 38.2 0.42 0.016 50.1 36.8 
Endocut 03 0.43 0.021 50.5 35.4 0.49 0.015 57.7 29.1 
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Control 0.13 0.008 15.1 0.0 0.73 0.030 86.9 0.0 
 
Table 11 – Hydrolysis results from skin: weight of freeze-dried hydrolysate (adjusted per 5 g for comparison) with standard deviation, percentage of total yield (relative to the dry 
weight of the material) and hydrolysate yield; weight of sediment (adjusted per 5 g for comparison) with standard deviation, percentage of sediment (relative to the dry weight of 
















to dry matter (%) 
Sediment reduction 
due to enzymatic 
hydrolysis (%) 
Alcalase 0.77 0.080 72.2 19.7 0.22 0.015 20.9 15.9 
Bromelain 0.71 0.018 66.2 13.7 0.23 0.009 21.4 15.4 
Corolase 2TS 0.80 0.057 74.6 22.1 0.20 0.020 18.8 18.0 
Corolase 7090 0.83 0.011 77.3 24.8 0.25 0.007 23.3 13.5 
Tail 10 0.81 0.066 75.5 23.0 0.26 0.015 24.1 12.7 
Tail 189 0.85 0.054 79.5 27.0 0.24 0.017 22.8 14.0 
Tail 190 0.85 0.015 79.4 26.9 0.25 0.007 23.6 13.2 
Tail 191 0.83 0.038 77.6 25.1 0.25 0.024 23.6 13.2 
Tail 192 0.84 0.008 78.9 26.4 0.24 0.001 22.6 14.2 
Tail 193 0.77 0.007 72.2 19.7 0.25 0.008 23.5 13.3 
Tail 194 0.88 0.026 82.0 29.5 0.24 0.003 22.8 14.0 
Tail 197 0.83 0.002 77.8 25.3 0.26 0.012 24.6 12.2 
FoodPro 30L 0.80 0.002 75.1 22.6 0.25 0.004 23.3 13.5 
FoodPro 51FP 0.84 0.006 78.8 26.3 0.26 0.006 24.5 12.3 
FoodPro PNL 0.80 0.026 75.2 22.7 0.26 0.009 24.0 12.8 
Veron L10 0.71 0.010 66.3 13.8 0.32 0.014 29.7 7.1 
Flavourzyme 0.85 0.017 79.3 26.8 0.30 0.004 27.7 9.1 
Protamex 0.88 0.003 81.9 29.4 0.25 0.000 23.2 13.6 
Promod 144GL 0.77 0.015 71.8 19.3 0.30 0.006 27.8 9.0 
Promod P950L 0.83 0.020 78.0 25.5 0.24 0.006 22.5 14.3 
Endocut 01 0.63 0.007 58.6 6.1 0.29 0.003 27.4 9.4 
Endocut 02 0.84 0.002 78.2 25.7 0.23 0.010 21.9 14.9 
Endocut 03 0.81 0.067 76.2 23.7 0.30 0.006 27.6 9.2 
Control 0.56 0.046 52.5 0.0 0.39 0.031 36.8 0.0 
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Table 12 – Hydrolysis results from bone: weight of freeze-dried hydrolysate (adjusted per 5 g for comparison) with standard deviation, percentage of total yield (relative to the dry 
weight of the material) and hydrolysate yield; weight of sediment (adjusted per 5 g for comparison) with standard deviation, percentage of sediment (relative to the dry weight of 
















to dry matter (%) 
Sediment reduction 
due to enzymatic 
hydrolysis (%) 
Alcalase 0.19 0.005 7.2 4.8 2.40 0.001 91.3 3.6 
Bromelain 0.17 0.002 6.4 4.0 2.43 0.004 92.5 2.4 
Corolase 2TS 0.18 0.001 6.9 4.5 2.45 0.002 93.5 1.5 
Corolase 7090 0.17 0.005 6.5 4.1 2.45 0.070 93.3 1.7 
Tail 10 0.18 0.007 7.0 4.6 2.40 0.029 91.6 3.4 
Tail 189 0.18 0.002 6.9 4.5 2.44 0.001 92.9 2.1 
Tail 190 0.20 0.000 7.8 5.4 2.36 0.001 89.7 5.3 
Tail 191 0.20 0.001 7.5 5.1 2.38 0.004 90.5 4.4 
Tail 192 0.19 0.001 7.3 4.9 2.34 0.017 89.1 5.9 
Tail 193 0.18 0.001 7.0 4.6 2.40 0.011 91.4 3.5 
Tail 194 0.19 0.005 7.1 4.7 2.36 0.038 89.7 5.3 
Tail 197 0.18 0.003 6.8 4.4 2.37 0.001 90.1 4.9 
FoodPro 30L 0.17 0.003 6.3 3.9 2.44 0.027 92.9 2.0 
FoodPro 51FP 0.17 0.003 6.4 4.0 2.44 0.005 92.9 2.1 
FoodPro PNL 0.17 0.006 6.5 4.1 2.44 0.014 93.0 2.0 
Veron L10 0.14 0.002 5.4 3.0 2.44 0.005 92.8 2.2 
Flavourzyme 0.14 0.006 5.4 3.0 2.44 0.033 93.0 2.0 
Protamex 0.18 0.003 6.9 4.5 2.38 0.005 90.7 4.3 
Promod 144GL 0.15 0.002 5.7 3.3 2.45 0.016 93.2 1.7 
Promod P950L 0.17 0.003 6.6 4.2 2.45 0.036 93.4 1.6 
Endocut 01 0.15 0.000 5.8 3.4 2.49 0.017 94.7 0.3 
Endocut 02 0.19 0.001 7.1 4.7 2.40 0.006 91.5 3.4 
Endocut 03 0.18 0.002 6.9 4.5 2.42 0.018 92.0 2.9 




A 4  Molecular weight distribution 
Table 13 – Molecular weight distribution of some hydrolysates produced from muscle. The hydrolysate produced by Tail 189 had the lowest average MW; the hydrolysate produced 
by Tail 191 had the highest yield, the hydrolysate produced by Corolase 2TS had high yield; the hydrolysate produced by Flavourzyme had the lowest yield and the highest 
average MW; the hydrolysate produced by Veron L10 had the second lowest yield. SEC results are shown for both replicates.  
 
Tail 189  Tail 191 Corolase 2TS Flavourzyme  Veron L10  
 
I II I II I II I II I II 
Peak# Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % 
Total 936 100 973 100 953 100 960 100 1565 100 1499 100 3650 100 3478 100 1370 100 1253 100 
1 6897 4.77 7283 5.1 3684 8.9 3578 9.2 6628 11.5 4191 21.2 16556 17.3 14746 18.5 4541 12.3 4281 10.3 
2 2063 3.16 2066 3.2 1282 14.0 1287 14.2 1976 10.0 1301 17.9 4219 3.3 3995 3.1 1978 11.8 1976 11.2 
3 1317 8.27 1323 8.1 843 29.9 847 29.8 1295 17.8 867 27.7 3013 4.2 2914 3.9 1293 18.7 1290 18.8 
4 850 23.18 854 22.6 464 40.9 467 40.5 866 27.7 671 1.6 2086 5.2 2022 5.3 860 25.3 858 26.0 
5 659 3.73 660 3.9 225 2.0 225 1.8 672 1.5 485 23.8 1365 9.0 1321 9.2 668 1.9 666 2.0 
6 478 32.73 481 31.9 86 0.7 86 0.6 485 23.8 308 2.4 878 15.2 861 15.6 464 22.0 460 23.2 
7 305 12.98 307 13.4 17 3.2 18 3.2 308 2.3 225 1.4 650 5.8 653 4.8 221 1.1 219 1.2 
8 223 6.29 225 6.9 0 0.1 0 0.1 224 1.3 95 0.3 476 15.8 476 15.6 27 4.9 27 5.0 
9 84 0.44 85 0.5 0 0.1 0 0.1 90 0.3 23 2.8 305 10.2 304 10.5 3 0.8 3 0.8 
10 17 3.89 17 3.8 0 0.1 0 0.1 22 2.8 2 0.5 218 5.1 218 5.5 0 0.4 0 0.4 
11 0 0.10 0 0.1 0 0.3 0 0.3 2 0.4 0 0.2 88 0.7 88 0.5 0 0.2 0 0.2 
12 0 0.05 0 0.1 0 0.0 0 0.0 0 0.2 0 0.3 23 6.0 22 5.7 0 0.7 0 0.7 
13 0 0.40 0 0.4 
    
0 0.3 
  
2 1.2 2 0.9 
    
14      
       
0 0.3 0 0.3 
    
15 
            
0 0.6 0 0.7 





Table 14 – Molecular weight distribution of some hydrolysates produced from skin. The hydrolysate produced by Tail 189 had the lowest average MW; the hydrolysate produced 
by Tail 194 had the highest yield, the hydrolysate produced by Protamex had high yield; the hydrolysate produced by Endocut 01 had the lowest yield; the hydrolysate produced 
by Veron L10 had also the highest average MW. SEC results are shown for both replicates.  
 Tail 189 Tail 194 Protamex Endocut 01 Veron L10 
 I II I II I II I II I II 
Peak
# 
Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % 
Total 1172 100 1214 100 1428 100 1472 100 2786 100 2837 100 3965 100 4148 100 13219 100 12856 100 
1 42610 0.2 43049 0.2 42456 0.2 46185 0.2 15479 6.6 15932 7.0 53440 1.2 54710 1.2 20850 59.3 20322 59.2 
2 5364 4.3 5472 4.9 6146 7.0 6217 7.2 5108 15.6 5019 15.6 15139 10.8 15323 11.6 4120 8.0 4019 7.7 
3 2500 5.4 2500 6.0 2546 6.4 2578 6.6 2641 10.4 2605 10.4 4963 15.2 4968 15.8 2801 8.4 2773 8.4 
4 1593 10.9 1593 11.9 1600 15.4 1613 15.8 1647 18.1 1629 18.1 2646 11.8 2649 12.1 1775 8.8 1764 9.1 
5 992 26.8 994 27.8 986 31.4 990 31.8 1020 24.8 1013 24.7 1641 16.1 1648 15.9 1066 8.3 1059 8.4 
6 602 38.3 604 38.1 601 32.8 606 32.5 598 20.7 594 20.6 1023 24.2 1026 23.6 628 5.5 625 5.5 
7 365 7.9 368 6.6 378 3.1 382 3.0 380 1.5 376 1.5 610 16.5 612 15.7 387 0.2 385 0.2 
8 280 2.7 281 2.1 281 1.0 284 0.9 275 0.4 272 0.4 382 1.3 383 1.3 298 0.1 296 0.1 
9 125 0.5 128 0.4 132 0.4 134 0.3 134 0.2 132 0.2 277 0.5 277 0.4 130 0.3 128 0.3 
10 48 0.8 59 0.4 59 0.4 60 0.3 46 0.6 45 0.6 149 0.1 148 0.1 43 0.4 42 0.4 
11 19 0.6 36 0.1 26 0.6 25 0.4 7 0.6 7 0.7 104 0.1 107 0.1 7 0.5 7 0.6 
12 6 1.3 19 0.6 6 1.0 7 0.8 1 0.2 1 0.2 44 0.6 45 0.7 1 0.1 1 0.1 
13 0 0.1 5 1.0 1 0.3 1 0.2 0 0.0 0 0.0 7 0.9 7 0.8 0 0.0 0 0.0 
14 0 0.1 0 0.1 0 0.0 0 0.0 0.00 0.0 0 0.0 1 0.3 1 0.3 
    
15 0 0.1 0 0.0 0 0.0 
      
0 0.1 0 0.1 
    
16     0 0.1 
      
    





Table 15 – Molecular weight distribution of some hydrolysates produced from bone. The hydrolysate produced by Tail 189 had the lowest average MW; the hydrolysate produced 
by Tail 190 had the highest yield, the hydrolysate produced by Alcalase had high yield; the hydrolysates produced by Veron L10 and Flavourzyme had the lowest yield; the 
hydrolysate produced by Veron L10 had the highest average MW. SEC results are shown for both replicates. 
 
Tail 189 Tail 190 Alcalase Veron L10 Flavourzyme 
 
I II I II I II I II I II 
Peak# Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % Mw % 
Total 1089 100 1042 100 1373 100 1350 100 1153 100 1153 100 10061 100 9402 100 1941 100 1958 100 
1 6491 4.17 6249 3.78 6522 5.63 6392 5.5 4202 8.9 4448 8.6 17732 51.6 17043 49.6 6578 15.3 6818 14.9 
2 2727 4.56 2722 4.37 2808 7.96 2785 7.8 1645 13.5 1644 13.1 4045 8.4 4083 9.1 2727 11.1 2781 11.2 
3 1701 9.03 1693 8.84 1682 14.76 1673 14.9 1003 31.4 997 31.2 2731 9.6 2736 9.9 1680 14.4 1695 14.1 
4 1032 24.08 1029 23.67 1025 31.18 1020 31.1 579 39.9 573 40.3 1704 9.3 1711 9.6 1029 21.0 1033 20.9 
5 590 40.81 586 41.14 586 34.04 583 34.2 372 2.4 369 2.6 1032 8.8 1037 9.2 589 22.7 588 22.6 
6 368 10.09 366 10.58 378 2.68 375 2.7 271 1.2 269 1.3 694 2.1 697 2.2 365 8.3 365 8.4 
7 281 4.51 279 4.71 275 1.25 273 1.2 129 0.3 129 0.3 543 5.2 545 5.4 273 3.7 273 3.8 
8 124 0.40 122 0.42 126 0.34 125 0.3 42 1.4 42 1.4 373 0.8 377 0.8 129 0.5 129 0.5 
9 49 0.88 46 1.01 42 1.23 41 1.3 6 0.6 6 0.6 278 0.6 283 0.6 41 1.9 42 2.1 
10 19 0.64 17 0.57 6 0.59 6 0.6 1 0.3 1 0.3 144 0.4 149 0.4 5 1.0 5 1.1 
11 5 0.79 5 0.79 1 0.28 1 0.3 0 0.2 0 0.2 42 1.7 43 1.7 0 0.1 0 0.2 
12 0 0.05 0 0.06 0 0.06 0 0.1 
    




        




            
    





Table 16 – Molecular weight distribution of protein fragments in the control treatment for muscle. All four 
replicates are presented. 
 
I II III IV 
Peak# Mw % Mw % Mw % Mw % 
Total 20692 100 22889 100 13731 100 12866 100 
1 60621 28.5 65583 29.5 67541 11.7 68484 12.6 
2 14493 22.3 15068 22.5 16278 34.7 15878 25.4 
3 1551 0.7 1545 0.6 1504 0.8 1554 0.9 
4 936 6.4 935 6.3 933 4.4 933 6.5 
5 703 6.4 703 6.1 691 6.0 689 7.5 
6 503 12.1 503 11.7 487 12.9 489 15.4 
7 367 1.2 367 1.2 357 1.3 359 1.3 
8 283 0.8 283 0.8 273 1.0 276 1.1 
9 127 3.1 128 2.8 125 3.2 128 4.3 
10 39 14.3 39 14.2 38 19.4 40 19.7 
11 7 1.7 6 1.9 5 2.5 6 3.3 
12 1 0.4 1 0.4 0 0.9 0 1.1 
13 0 0.8 0 0.8 0 1.3 0 0.9 
14 0 0.4 0 0.4 
    
15 0 0.8 0 0.9 
    
 
Table 17  – Molecular weight distribution of protein fragments in the control treatment for skin. All four replicates 
are presented. 
 
I II III IV 
Peak# Mw % Mw % Mw % Mw % 
Total 74367 100 76779 100 80533 100 77556 100 
1 408466 8.0 405978 9.7 443319 8.6 454826 8.8 
2 47727 87.4 43804 85.3 48330 87.4 43051 87.2 
3 1740 1.1 1734 1.2 1734 1.0 1702 1.1 
4 1044 0.8 1039 0.9 1050 0.8 1033 0.7 
5 736 0.2 733 0.2 732 0.2 731 0.2 
6 619 0.3 616 0.4 616 0.3 613 0.3 
7 546 0.1 542 0.1 542 0.1 541 0.1 
8 486 0.3 484 0.3 483 0.2 482 0.2 
9 392 0.1 389 0.1 390 0.1 390 0.1 
10 313 0.1 310 0.1 312 0.0 310 0.0 
11 129 0.1 127 0.1 128 0.0 128 0.1 
12 45 0.4 44 0.4 44 0.4 44 0.4 
13 6 1.1 6 1.2 7 0.7 7 0.8 





Table 18  – Molecular weight distribution of protein fragments in the control treatment for bone. All four replicates 
are presented. 
 
I II III IV 
Peak# Mw % Mw % Mw % Mw % 
Total 42505 100 41677 100 36135 100 35920 100 
1 50188 84.5 49914 83.3 44813 80.4 44318 80.9 
2 1664 1.3 1669 1.3 1652 1.4 1645 1.4 
3 1009 1.3 1015 1.3 1013 1.3 1010 1.3 
4 693 1.7 690 1.8 688 2.2 690 2.2 
5 505 3.6 501 4.0 496 4.8 498 4.6 
6 363 0.9 363 1.0 360 1.1 360 1.1 
7 275 0.7 276 0.7 274 0.9 273 0.9 
8 189 0.1 192 0.2 189 0.2 189 0.2 
9 130 0.5 130 0.5 130 0.6 129 0.6 
10 40 3.2 41 3.6 41 4.2 40 4.2 
11 5 1.9 6 2.1 6 2.5 5 2.3 







A 5 Bioactivity 
A 5.1. Determination of hydrolysates’ test concentration for antioxidant assay. 
Based on results shown in Table 19, test concentration of 100 µg/mL was considered to be high 
relatively to Trolox concentrations used for plotting of the standard curve, while the next tested 
concentration 10 µg/mL was relatively low. Therefore, the decision was made to test all the 
hydrolysates at concentration 50 µg/mL. 





Trolox equivalent (µM) 
Muscle Skin Bone 
Alcalase 100 4.3 3.3 2.5 
10 0.1 0.0 0.0 
1 -0.7 -0.8 -0.9 
0.1 -1.0 -1.0 -1.0 
Tail 190 100 4.7 2.5 2.9 
10 0.2 -0.1 -0.1 
1 -0.8 -0.8 -0.9 
0.1 -1.0 -0.9 -1.0 
Endocut 02 100 4.5 3.3 2.7 
10 0.3 0.0 0.1 
1 -0.7 -0.9 -0.7 













A 5.2. Determination of hydrolysates’ test concentration for anti-inflammatory assay. 
As Table 20 shows, no correlation between concentrations and inhibition was observed, 
indicating that the assay was not performed correctly. Therefore, due to time limitation, the 
decision was made to use concentration 100 µg/mL for testing all the hydrolysates as the 
concentration in the middle of the tested range. 
Table 20 – Concentration test for anti-inflammatory assay. 









































A 5.3. Survival rate of human melanoma cells 
Table 21 – Survival rate of human melanoma A2058 cells in Aqueous One Solution Cell Proliferation assay for 
hydrolysates (average of two replicates) from cod muscle, skin and bone produced by 23 enzymes and control 
(without addition of enzyme). Final concentration of hydrolysates was 1 mg/mL. 
Enzyme 
Survival rate (%) 
muscle skin bone 
Alcalase 114.7 94.6 102.6 
Bromelain 115.6 96.6 99.0 
Corolase 2TS 113.1 93.2 100.9 
Corolase 7090 113.3 97.7 99.0 
Tail 10 95.9 99.5 89.6 
Tail 189 106.5 97.2 90.9 
Tail 190 96.5 102.6 95.4 
Tail 191 96.1 96.8 86.5 
Tail 192 117.7 96.6 82.0 
Tail 193 108.2 97.2 81.0 
Tail 194 110.5 99.7 84.3 
Tail 197 109.6 95.9 81.6 
FoodPro 30L 113.2 103.0 74.4 
FoodPro 51FP 101.6 105.8 75.0 
FoodPro PNL 108.3 103.0 75.4 
Veron L10 107.2 104.5 75.1 
Flavourzyme 115.8 91.8 113.8 
Protamex 113.4 92.9 107.2 
Promod 144GL 119.9 84.6 100.3 
Promod P950L 113.7 91.1 98.3 
Endocut 01 106.2 103.1 100.4 
Endocut 02 107.9 97.7 93.9 
Endocut 03 116.8 101.4 88.0 





A 5.4. Anti-inflammatory properties of hydrolysates 
Table 22 – Inhibition of TNF-α expression by THP-1 cells stimulated by LPS. Test concentration 100 µg/mL. 
Enzyme 
Inhibition of TNF-alpha production (%) 
Muscle Skin Bone 
Alcalase -1.3 8.1 14.9 
Bromelain 1.9 6.7 13.8 
Corolase 2TS -3.7 -1.5 13.3 
Corolase 7090 -2.0 -11.2 23.7 
Tail 10 -7.7 -11.2 19.3 
Tail 189 -0.8 -10.7 23.1 
Tail 190 6.6 -2.8 12.6 
Tail 191 2.9 -19.9 21.4 
Tail 192 -9.7 -12.6 14.3 
Tail 193 7.1 -14.5 7.1 
Tail 194 3.8 -7.4 18.4 
Tail 197 0.9 19.5 8.7 
FoodPro 30L 13.2 -8.7 0.9 
FoodPro 51FP 15.2 -12.0 -2.9 
FoodPro PNL 17.9 1.7 28.8 
Veron L10 13.3 14.3 17.0 
Flavourzyme 18.2 -2.5 15.2 
Protamex 19.7 -1.2 17.9 
Promod 144GL 17.9 -10.9 -3.7 
Promod P950L 15.4 16.1 2.4 
Endocut 01 1.9 1.2 -5.2 
Endocut 02 -2.9 -6.5 3.5 
Endocut 03 6.9 -8.7 26.0 
Control 3.3 16.2 18.4 
 
 
 
 
